<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00661713</url>
  </required_header>
  <id_info>
    <org_study_id>V72P10</org_study_id>
    <nct_id>NCT00661713</nct_id>
  </id_info>
  <brief_title>Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules</brief_title>
  <official_title>A Phase 2b/3, Multi-Center, Observer-Blind, Controlled Study of the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents Aged 11-17 Years According to Different Vaccination Schedules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Vaccines</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      The proposed study is aimed to assess the antibody response and short-term persistence of
      Novartis Meningococcal B Vaccine after one, two or three doses and to evaluate the optimal
      vaccination schedule in an adolescent population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentages 'of Subjects With hSBA Titer ≥1:4 After Receiving One, Two or Three Doses of rMenB+OMV NZ Vaccine.</measure>
    <time_frame>Month-1, 2, 3</time_frame>
    <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titter &gt;1:4 against 44/76-SL, 5/99, NZ98/254 strains at months 1, 2, 3.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Local Reactions and Systemic Reactions Occurring in Days 1 to 7 After Vaccination</measure>
    <time_frame>1 to 7 days after each vaccination</time_frame>
    <description>Safety was assessed as the number of subjects who reported local and systemic reactions during day 1 to day 7 after any vaccination with rMenB+OMV</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With hSBA Titer ≥1:4 After Receiving a Booster Dose of rMenB+OMV NZ Vaccine at Month 6.</measure>
    <time_frame>Month-6 &amp; 7</time_frame>
    <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titter &gt;1:4 agains 44/76-SL, 5/99, NZ98/254 strains at months 6 &amp; 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With hSBA Titer ≥1:8 After Primary and Booster Vaccination.</measure>
    <time_frame>at baseline, month-1, month-2, month-3, month-6 and month-7.</time_frame>
    <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titer ≥1:8 against 44/76-SL, 5/99, NZ98/254 strains.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of Subjects With at Least a Fourfold Rise in hSBA Titer Over the Prevaccination and After Booster Vaccination.</measure>
    <time_frame>Month-1, month-2, month-3 and month-7</time_frame>
    <description>Immunogenicity was evaluated by measuring the percentage of subjects with at least a fourfold rise in hSBA titer over the prevaccination and after booster vaccination against 44/76-SL, 5/99, NZ98/254 strains at month-1, month-2, month-3 and month-7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titers (GMTs) After Primary and Booster Vaccination.</measure>
    <time_frame>month-1, month-2, month-3, month-6 and month-7</time_frame>
    <description>Immunogenicity was evaluated by measuring the Geometric mean titers (GMTs) after primary and booster vaccination against 44/76-SL, 5/99, NZ98/254.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Ratios (GMRs) After Primary and Booster Vaccination.</measure>
    <time_frame>month-1, month-2, month-3, month-6 and month-7</time_frame>
    <description>Immunogenicity was evaluated by measuring the Geometric mean ratios (GMRs) after primary and booster vaccination against 44/76-SL, 5/99, NZ98/254.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GMCs of Antibodies Against 287-953Antigen (ELISA) After Primary and Booster Vaccination.</measure>
    <time_frame>month-1, month-2, month-3, month-6 and month-7</time_frame>
    <description>Immunogenicity was evaluated by measuring the Geometric mean Concentration (GMCs) after primary and booster vaccination against Antigen 287-953 Antigen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GMRs of Antibodies Against 287-953Antigen (ELISA) After Primary and Booster Vaccination</measure>
    <time_frame>month-1, month-2, month-3, month-6 and month-7</time_frame>
    <description>Immunogenicity was evaluated by measuring the Geometric mean Ratios (GMRs) after primary and booster vaccination against 287-953Antigen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects Reporting Unsolicited AEs Throughout the Study.</measure>
    <time_frame>Throughout the study</time_frame>
    <description>Safety was assessed as the number of subjects who reported unsolicited AEs throughout the study.</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">1631</enrollment>
  <condition>Meningococcal Disease</condition>
  <arm_group>
    <arm_group_label>rMenB06</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received one injection of rMenB+OMV NZ vaccine (month 0) and two injections of placebo (at month 1, month 2). A second injection of rMenB+OMV NZ vaccine was given later (month 6).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rMenB0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received one injection of rMenB+OMV NZ vaccine (month 0) and three injections of placebo (month 1, month 2 and month 6).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rMenB016</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received two injections of rMenB+OMV NZ vaccine (at month 0 and month 1) and one injection of placebo (at month 2). A third injection of rMenB+OMV NZ vaccine was given later (at month 6).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rMenB01</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received two injections of rMenB+OMV NZ vaccine (at month 0 and month 1) and two injection of placebo (at month 2 and month 6).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rMenB026</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received two injections of rMenB+OMV NZ vaccine (at month 0 and month 2) and one injection of placebo (at month 2). A third injection of rMenB+OMV NZ vaccine was given later (at month 6).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rMenB02</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received two injections of rMenB+OMV NZ vaccine (at month 0 and month 2) and two injections of placebo (at month 1 and month 6).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rMenB012</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received three injections of rMenB+OMV NZ vaccine (at month 0, month 1 and month 2) and one injection of placebo later (at month 6).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rMenB6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received three injections of placebo(at month 0, month 1 and month 2) and one injection of rMenB+OMV NZ vaccine(at month 6).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>rMenB+OMV NZ</intervention_name>
    <arm_group_label>rMenB06</arm_group_label>
    <arm_group_label>rMenB0</arm_group_label>
    <arm_group_label>rMenB016</arm_group_label>
    <arm_group_label>rMenB01</arm_group_label>
    <arm_group_label>rMenB026</arm_group_label>
    <arm_group_label>rMenB02</arm_group_label>
    <arm_group_label>rMenB012</arm_group_label>
    <arm_group_label>rMenB6</arm_group_label>
    <other_name>Serogroup B Meningococcal Vaccine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>rMenB06</arm_group_label>
    <arm_group_label>rMenB0</arm_group_label>
    <arm_group_label>rMenB016</arm_group_label>
    <arm_group_label>rMenB01</arm_group_label>
    <arm_group_label>rMenB026</arm_group_label>
    <arm_group_label>rMenB02</arm_group_label>
    <arm_group_label>rMenB012</arm_group_label>
    <arm_group_label>rMenB6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1)11-17 years of age inclusive who have given their written assent and whose parents or
        legal guardians have given written informed consent at the time of enrollment;

        2)who are available for all the visits scheduled in the study (i.e., not planning to leave
        the area before the end of the study period);

        3)in good health as determined by the outcome of medical history, physical examination and
        clinical judgment of the investigator.

        Exclusion Criteria:

          1. History of any meningococcal B vaccine administration;

          2. Current or previous, confirmed or suspected disease caused by N. meningitidis;

          3. Household contact with and/or intimate exposure to an individual with any laboratory
             confirmed N. meningitidis infection within 60 days of enrollment;

          4. Significant acute or chronic infection within the previous 7 days or fever (defined as
             axillary temperature ≥38°C) within the previous day;

          5. Antibiotics within 6 days prior to enrollment;

          6. Pregnancy or nursing (breastfeeding) mothers;

          7. Females of childbearing age who have not used or do not plan to use acceptable birth
             control measures, for the 7 months duration of the study. Oral, injected or implanted
             hormonal contraceptive, diaphragm, condom, intrauterine device or sexual abstinence
             are considered acceptable forms of birth control. If sexually active the subject must
             have been using one of the accepted birth control methods at least two months prior to
             study entry;

          8. Any serious chronic or progressive disease (e.g., neoplasm, diabetes, cardiac disease,
             hepatic disease, progressive neurological disease or seizure disorder; autoimmune
             disease, HIV infection or AIDS, or blood dyscrasias or diathesis, signs of cardiac or
             renal failure or severe malnutrition).

          9. Known or suspected impairment/alteration of the immune system, immunosuppressive
             therapy, including use of corticosteroids in immunosuppressive doses or chronic use of
             inhaled high-potency corticosteroids within the previous 60 days. [Use of topical
             corticosteroids administered during the study in limited areas (i.e., eczema on knees
             or face or elbows) of the body is allowed]; immunostimulants;

         10. Receipt of blood, blood products and/or plasma derivatives, or a parenteral
             immunoglobulin preparation within the previous 90 days;

         11. History of severe allergic reactions after previous vaccinations or hypersensitivity
             to any vaccine component;

         12. Receipt of or intent to immunize with any other vaccine(s) within 30 days prior (60
             days for live viral vaccines) and throughout the study period (exception: licensed
             fluvaccine should not be administered within 14 days prior to enrollment; routine
             vaccine administration may be administered after the blood draw at Study Month 7);

         13. Participation in another clinical trial within the last 90 days or planned for during
             study;

         14. Family members and household members of research staff;

         15. Any condition which in the opinion of the investigator and/or the Regional MD may
             interfere with the evaluation of the study objectives.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Vaccines</last_name>
    <role>Study Chair</role>
    <affiliation>Novartis Vaccines</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Site 13: Liceo Diego Aracena de Lo Barnechea</name>
      <address>
        <city>Monseñor Escrivá de Balaguer 14630, Lo Barnechea</city>
        <state>Santiago</state>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 41: Colegio Antonio Hermida Fabres</name>
      <address>
        <city>Av. Coronel Alejandro Sepúlveda n° 6801</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 43: Liceo José Victorino Lastarria</name>
      <address>
        <city>Av. Miguel Claro n° 32</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 51: Centro Para vacunas en Desarrollo. Hospital de Niños Roberto del Rio</name>
      <address>
        <city>Av. Prof Zañartu 1085</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 15: Liceo Carmela Carvajal de Prat</name>
      <address>
        <city>Avda. Italia 980</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 14: Colegio Parroquial Santa Rosa de Lo Barnechea</name>
      <address>
        <city>Avda. Raúl Labbé Nº 13.799</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 42: Centro Educacional Eduardo de la Barra</name>
      <address>
        <city>Calle A, n° 6301</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 61: Facultad de Medicina. Universidad de Valparaíso.</name>
      <address>
        <city>Hontaneda # 2653. Valparaíso</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 11: Complejo Educacional Eduardo Cuevas Valdés</name>
      <address>
        <city>Lo Barnechea</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 12: Colegio San Jose de Lo Barnechea</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2008</study_first_submitted>
  <study_first_submitted_qc>April 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2008</study_first_posted>
  <results_first_submitted>February 3, 2015</results_first_submitted>
  <results_first_submitted_qc>October 7, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 4, 2015</results_first_posted>
  <last_update_submitted>October 7, 2015</last_update_submitted>
  <last_update_submitted_qc>October 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Meningococcal disease</keyword>
  <keyword>Neisseria meningitidis serogroup B</keyword>
  <keyword>prevention</keyword>
  <keyword>vaccination</keyword>
  <keyword>adolescents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningococcal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were enrolled at 10 study centers in Chile.</recruitment_details>
      <pre_assignment_details>All enrolled subjects were included in the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>rMenB06</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
        </group>
        <group group_id="P2">
          <title>rMenB0</title>
          <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
        </group>
        <group group_id="P3">
          <title>rMenB016</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
        </group>
        <group group_id="P4">
          <title>rMenB01</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
        </group>
        <group group_id="P5">
          <title>rMenB026</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
        </group>
        <group group_id="P6">
          <title>rMenB02</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
        </group>
        <group group_id="P7">
          <title>rMenB012</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
        </group>
        <group group_id="P8">
          <title>rMenB6</title>
          <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="128"/>
                <participants group_id="P2" count="247"/>
                <participants group_id="P3" count="128"/>
                <participants group_id="P4" count="247"/>
                <participants group_id="P5" count="127"/>
                <participants group_id="P6" count="253"/>
                <participants group_id="P7" count="373"/>
                <participants group_id="P8" count="128"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="112"/>
                <participants group_id="P2" count="208"/>
                <participants group_id="P3" count="111"/>
                <participants group_id="P4" count="219"/>
                <participants group_id="P5" count="107"/>
                <participants group_id="P6" count="216"/>
                <participants group_id="P7" count="309"/>
                <participants group_id="P8" count="117"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="39"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="28"/>
                <participants group_id="P5" count="20"/>
                <participants group_id="P6" count="37"/>
                <participants group_id="P7" count="64"/>
                <participants group_id="P8" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unable to Classify</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="21"/>
                <participants group_id="P5" count="12"/>
                <participants group_id="P6" count="26"/>
                <participants group_id="P7" count="45"/>
                <participants group_id="P8" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="7"/>
                <participants group_id="P7" count="14"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Administrative Reason</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inappropriate Enrollment</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>rMenB06</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
        </group>
        <group group_id="B2">
          <title>rMenB0</title>
          <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
        </group>
        <group group_id="B3">
          <title>rMenB016</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
        </group>
        <group group_id="B4">
          <title>rMenB01</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
        </group>
        <group group_id="B5">
          <title>rMenB026</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
        </group>
        <group group_id="B6">
          <title>rMenB02</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
        </group>
        <group group_id="B7">
          <title>rMenB012</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
        </group>
        <group group_id="B8">
          <title>rMenB6</title>
          <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
        </group>
        <group group_id="B9">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="128"/>
            <count group_id="B2" value="247"/>
            <count group_id="B3" value="128"/>
            <count group_id="B4" value="247"/>
            <count group_id="B5" value="127"/>
            <count group_id="B6" value="253"/>
            <count group_id="B7" value="373"/>
            <count group_id="B8" value="128"/>
            <count group_id="B9" value="1631"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.8" spread="1.9"/>
                    <measurement group_id="B2" value="13.8" spread="1.9"/>
                    <measurement group_id="B3" value="13.9" spread="1.9"/>
                    <measurement group_id="B4" value="13.9" spread="1.9"/>
                    <measurement group_id="B5" value="13.7" spread="1.9"/>
                    <measurement group_id="B6" value="13.7" spread="1.8"/>
                    <measurement group_id="B7" value="13.8" spread="1.9"/>
                    <measurement group_id="B8" value="13.8" spread="2"/>
                    <measurement group_id="B9" value="13.8" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="76"/>
                    <measurement group_id="B4" value="138"/>
                    <measurement group_id="B5" value="73"/>
                    <measurement group_id="B6" value="138"/>
                    <measurement group_id="B7" value="199"/>
                    <measurement group_id="B8" value="66"/>
                    <measurement group_id="B9" value="913"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="52"/>
                    <measurement group_id="B4" value="109"/>
                    <measurement group_id="B5" value="54"/>
                    <measurement group_id="B6" value="115"/>
                    <measurement group_id="B7" value="174"/>
                    <measurement group_id="B8" value="62"/>
                    <measurement group_id="B9" value="718"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentages ‘of Subjects With hSBA Titer ≥1:4 After Receiving One, Two or Three Doses of rMenB+OMV NZ Vaccine.</title>
        <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titter &gt;1:4 against 44/76-SL, 5/99, NZ98/254 strains at months 1, 2, 3.</description>
        <time_frame>Month-1, 2, 3</time_frame>
        <population>Analysis was performed as per the protocol dataset</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages ‘of Subjects With hSBA Titer ≥1:4 After Receiving One, Two or Three Doses of rMenB+OMV NZ Vaccine.</title>
          <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titter &gt;1:4 against 44/76-SL, 5/99, NZ98/254 strains at months 1, 2, 3.</description>
          <population>Analysis was performed as per the protocol dataset</population>
          <units>percentage of Subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="223"/>
                <count group_id="O3" value="113"/>
                <count group_id="O4" value="231"/>
                <count group_id="O5" value="110"/>
                <count group_id="O6" value="232"/>
                <count group_id="O7" value="334"/>
                <count group_id="O8" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>44/76-SL- Mo 0 N= 112,223,113,231,110,232,334,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="33" upper_limit="52"/>
                    <measurement group_id="O2" value="47" lower_limit="40" upper_limit="54"/>
                    <measurement group_id="O3" value="41" lower_limit="32" upper_limit="50"/>
                    <measurement group_id="O4" value="38" lower_limit="32" upper_limit="45"/>
                    <measurement group_id="O5" value="37" lower_limit="28" upper_limit="47"/>
                    <measurement group_id="O6" value="47" lower_limit="40" upper_limit="53"/>
                    <measurement group_id="O7" value="46" lower_limit="41" upper_limit="52"/>
                    <measurement group_id="O8" value="46" lower_limit="36" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 1 N= 112,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="85" upper_limit="96"/>
                    <measurement group_id="O2" value="92" lower_limit="88" upper_limit="95"/>
                    <measurement group_id="O3" value="95" lower_limit="89" upper_limit="98"/>
                    <measurement group_id="O4" value="93" lower_limit="88" upper_limit="96"/>
                    <measurement group_id="O5" value="90" lower_limit="83" upper_limit="95"/>
                    <measurement group_id="O6" value="92" lower_limit="88" upper_limit="95"/>
                    <measurement group_id="O7" value="95" lower_limit="92" upper_limit="97"/>
                    <measurement group_id="O8" value="43" lower_limit="34" upper_limit="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 2 N=108,213,108,222,105,219,307,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="80" upper_limit="93"/>
                    <measurement group_id="O2" value="92" lower_limit="88" upper_limit="95"/>
                    <measurement group_id="O3" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O4" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O5" value="88" lower_limit="80" upper_limit="93"/>
                    <measurement group_id="O6" value="89" lower_limit="85" upper_limit="93"/>
                    <measurement group_id="O7" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O8" value="50" lower_limit="40" upper_limit="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 3 N=107,208,105,215,104,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" lower_limit="76" upper_limit="90"/>
                    <measurement group_id="O2" value="88" lower_limit="82" upper_limit="92"/>
                    <measurement group_id="O3" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O4" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O5" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O6" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O7" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O8" value="48" lower_limit="38" upper_limit="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 0 N = 112,223,113,231,110,232,334,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="20" upper_limit="38"/>
                    <measurement group_id="O2" value="41" lower_limit="35" upper_limit="48"/>
                    <measurement group_id="O3" value="28" lower_limit="20" upper_limit="38"/>
                    <measurement group_id="O4" value="31" lower_limit="25" upper_limit="38"/>
                    <measurement group_id="O5" value="30" lower_limit="22" upper_limit="39"/>
                    <measurement group_id="O6" value="37" lower_limit="31" upper_limit="44"/>
                    <measurement group_id="O7" value="36" lower_limit="30" upper_limit="41"/>
                    <measurement group_id="O8" value="29" lower_limit="21" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 1 N = 111,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="92" upper_limit="99"/>
                    <measurement group_id="O2" value="96" lower_limit="93" upper_limit="98"/>
                    <measurement group_id="O3" value="96" lower_limit="90" upper_limit="99"/>
                    <measurement group_id="O4" value="97" lower_limit="94" upper_limit="99"/>
                    <measurement group_id="O5" value="97" lower_limit="92" upper_limit="99"/>
                    <measurement group_id="O6" value="95" lower_limit="92" upper_limit="98"/>
                    <measurement group_id="O7" value="97" lower_limit="94" upper_limit="98"/>
                    <measurement group_id="O8" value="35" lower_limit="26" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 2 N=108,213,108,222,105,219,308,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="90" upper_limit="98"/>
                    <measurement group_id="O2" value="94" lower_limit="90" upper_limit="97"/>
                    <measurement group_id="O3" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O4" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O5" value="97" lower_limit="92" upper_limit="99"/>
                    <measurement group_id="O6" value="96" lower_limit="93" upper_limit="98"/>
                    <measurement group_id="O7" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O8" value="31" lower_limit="23" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 3 N=107,209,105,215,105,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="85" upper_limit="96"/>
                    <measurement group_id="O2" value="89" lower_limit="84" upper_limit="93"/>
                    <measurement group_id="O3" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O4" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O5" value="98" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O6" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O7" value="100" lower_limit="99" upper_limit="100"/>
                    <measurement group_id="O8" value="32" lower_limit="24" upper_limit="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254-mo 0 N = 112,223,113,231,110,232,333,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32" lower_limit="24" upper_limit="42"/>
                    <measurement group_id="O2" value="39" lower_limit="33" upper_limit="46"/>
                    <measurement group_id="O3" value="33" lower_limit="24" upper_limit="42"/>
                    <measurement group_id="O4" value="35" lower_limit="29" upper_limit="41"/>
                    <measurement group_id="O5" value="34" lower_limit="25" upper_limit="43"/>
                    <measurement group_id="O6" value="37" lower_limit="31" upper_limit="44"/>
                    <measurement group_id="O7" value="33" lower_limit="28" upper_limit="38"/>
                    <measurement group_id="O8" value="38" lower_limit="29" upper_limit="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254-mo 1 N = 111,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90" lower_limit="83" upper_limit="95"/>
                    <measurement group_id="O2" value="94" lower_limit="90" upper_limit="97"/>
                    <measurement group_id="O3" value="95" lower_limit="89" upper_limit="98"/>
                    <measurement group_id="O4" value="94" lower_limit="90" upper_limit="96"/>
                    <measurement group_id="O5" value="90" lower_limit="83" upper_limit="95"/>
                    <measurement group_id="O6" value="93" lower_limit="89" upper_limit="96"/>
                    <measurement group_id="O7" value="95" lower_limit="92" upper_limit="97"/>
                    <measurement group_id="O8" value="38" lower_limit="29" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254-mo 2 N=107,213,108,222,105,218,308,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="73" upper_limit="88"/>
                    <measurement group_id="O2" value="84" lower_limit="74" upper_limit="88"/>
                    <measurement group_id="O3" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O4" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O5" value="78" lower_limit="69" upper_limit="86"/>
                    <measurement group_id="O6" value="85" lower_limit="79" upper_limit="89"/>
                    <measurement group_id="O7" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O8" value="39" lower_limit="29" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254-mo 3 N=107,208,105,215,104,215,302,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80" lower_limit="72" upper_limit="87"/>
                    <measurement group_id="O2" value="76" lower_limit="70" upper_limit="82"/>
                    <measurement group_id="O3" value="97" lower_limit="92" upper_limit="99"/>
                    <measurement group_id="O4" value="97" lower_limit="94" upper_limit="99"/>
                    <measurement group_id="O5" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O6" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O7" value="99" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O8" value="43" lower_limit="33" upper_limit="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Local Reactions and Systemic Reactions Occurring in Days 1 to 7 After Vaccination</title>
        <description>Safety was assessed as the number of subjects who reported local and systemic reactions during day 1 to day 7 after any vaccination with rMenB+OMV</description>
        <time_frame>1 to 7 days after each vaccination</time_frame>
        <population>Analysis was performed as per the safety dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Local Reactions and Systemic Reactions Occurring in Days 1 to 7 After Vaccination</title>
          <description>Safety was assessed as the number of subjects who reported local and systemic reactions during day 1 to day 7 after any vaccination with rMenB+OMV</description>
          <population>Analysis was performed as per the safety dataset.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="128"/>
                <count group_id="O2" value="247"/>
                <count group_id="O3" value="128"/>
                <count group_id="O4" value="247"/>
                <count group_id="O5" value="127"/>
                <count group_id="O6" value="253"/>
                <count group_id="O7" value="373"/>
                <count group_id="O8" value="128"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>erythema (local)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                    <measurement group_id="O2" value="162"/>
                    <measurement group_id="O3" value="95"/>
                    <measurement group_id="O4" value="188"/>
                    <measurement group_id="O5" value="94"/>
                    <measurement group_id="O6" value="172"/>
                    <measurement group_id="O7" value="282"/>
                    <measurement group_id="O8" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration (Local)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                    <measurement group_id="O2" value="130"/>
                    <measurement group_id="O3" value="75"/>
                    <measurement group_id="O4" value="151"/>
                    <measurement group_id="O5" value="82"/>
                    <measurement group_id="O6" value="121"/>
                    <measurement group_id="O7" value="228"/>
                    <measurement group_id="O8" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling (Local)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="132"/>
                    <measurement group_id="O3" value="81"/>
                    <measurement group_id="O4" value="144"/>
                    <measurement group_id="O5" value="76"/>
                    <measurement group_id="O6" value="115"/>
                    <measurement group_id="O7" value="226"/>
                    <measurement group_id="O8" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain (Local)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122"/>
                    <measurement group_id="O2" value="236"/>
                    <measurement group_id="O3" value="124"/>
                    <measurement group_id="O4" value="237"/>
                    <measurement group_id="O5" value="113"/>
                    <measurement group_id="O6" value="236"/>
                    <measurement group_id="O7" value="345"/>
                    <measurement group_id="O8" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Med.Att Fever (Systemic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malaise (Systemic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                    <measurement group_id="O2" value="181"/>
                    <measurement group_id="O3" value="96"/>
                    <measurement group_id="O4" value="172"/>
                    <measurement group_id="O5" value="87"/>
                    <measurement group_id="O6" value="185"/>
                    <measurement group_id="O7" value="272"/>
                    <measurement group_id="O8" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia(Systemic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                    <measurement group_id="O2" value="141"/>
                    <measurement group_id="O3" value="91"/>
                    <measurement group_id="O4" value="156"/>
                    <measurement group_id="O5" value="81"/>
                    <measurement group_id="O6" value="160"/>
                    <measurement group_id="O7" value="238"/>
                    <measurement group_id="O8" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia(Systemic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="76"/>
                    <measurement group_id="O3" value="55"/>
                    <measurement group_id="O4" value="80"/>
                    <measurement group_id="O5" value="39"/>
                    <measurement group_id="O6" value="105"/>
                    <measurement group_id="O7" value="146"/>
                    <measurement group_id="O8" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache(Systemic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="139"/>
                    <measurement group_id="O3" value="88"/>
                    <measurement group_id="O4" value="160"/>
                    <measurement group_id="O5" value="73"/>
                    <measurement group_id="O6" value="165"/>
                    <measurement group_id="O7" value="244"/>
                    <measurement group_id="O8" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea(Systemic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="80"/>
                    <measurement group_id="O3" value="51"/>
                    <measurement group_id="O4" value="72"/>
                    <measurement group_id="O5" value="42"/>
                    <measurement group_id="O6" value="88"/>
                    <measurement group_id="O7" value="143"/>
                    <measurement group_id="O8" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever(Systemic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="21"/>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="26"/>
                    <measurement group_id="O7" value="38"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With hSBA Titer ≥1:4 After Receiving a Booster Dose of rMenB+OMV NZ Vaccine at Month 6.</title>
        <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titter &gt;1:4 agains 44/76-SL, 5/99, NZ98/254 strains at months 6 &amp; 7.</description>
        <time_frame>Month-6 &amp; 7</time_frame>
        <population>Analysis was performed as per the protocol dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With hSBA Titer ≥1:4 After Receiving a Booster Dose of rMenB+OMV NZ Vaccine at Month 6.</title>
          <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titter &gt;1:4 agains 44/76-SL, 5/99, NZ98/254 strains at months 6 &amp; 7.</description>
          <population>Analysis was performed as per the protocol dataset.</population>
          <units>percentage of Subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="188"/>
                <count group_id="O3" value="100"/>
                <count group_id="O4" value="198"/>
                <count group_id="O5" value="99"/>
                <count group_id="O6" value="201"/>
                <count group_id="O7" value="278"/>
                <count group_id="O8" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>44/76-SL- Mo 6 N = 100,188,100,198,99,201,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76" lower_limit="66" upper_limit="84"/>
                    <measurement group_id="O2" value="72" lower_limit="65" upper_limit="79"/>
                    <measurement group_id="O3" value="93" lower_limit="86" upper_limit="97"/>
                    <measurement group_id="O4" value="92" lower_limit="88" upper_limit="96"/>
                    <measurement group_id="O5" value="97" lower_limit="91" upper_limit="99"/>
                    <measurement group_id="O6" value="98" lower_limit="94" upper_limit="99"/>
                    <measurement group_id="O7" value="97" lower_limit="94" upper_limit="99"/>
                    <measurement group_id="O8" value="46" lower_limit="36" upper_limit="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 7 N=86,173,95,186,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O2" value="71" lower_limit="64" upper_limit="78"/>
                    <measurement group_id="O3" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O4" value="90" lower_limit="85" upper_limit="94"/>
                    <measurement group_id="O5" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O6" value="95" lower_limit="91" upper_limit="98"/>
                    <measurement group_id="O7" value="95" lower_limit="92" upper_limit="98"/>
                    <measurement group_id="O8" value="93" lower_limit="85" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 6 N=100,188,100,198,99,201,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="70" upper_limit="87"/>
                    <measurement group_id="O2" value="74" lower_limit="67" upper_limit="80"/>
                    <measurement group_id="O3" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O4" value="98" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O5" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O6" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O7" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O8" value="28" lower_limit="19" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 7 N=86,173,95,187,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="94" upper_limit="100"/>
                    <measurement group_id="O2" value="67" lower_limit="60" upper_limit="74"/>
                    <measurement group_id="O3" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O4" value="98" lower_limit="95" upper_limit="99"/>
                    <measurement group_id="O5" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O6" value="99" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O7" value="99" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O8" value="93" lower_limit="85" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254-mo 6 N=99,188,100,198,99,200,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="72" upper_limit="88"/>
                    <measurement group_id="O2" value="69" lower_limit="62" upper_limit="76"/>
                    <measurement group_id="O3" value="93" lower_limit="86" upper_limit="97"/>
                    <measurement group_id="O4" value="89" lower_limit="84" upper_limit="93"/>
                    <measurement group_id="O5" value="97" lower_limit="91" upper_limit="99"/>
                    <measurement group_id="O6" value="96" lower_limit="92" upper_limit="98"/>
                    <measurement group_id="O7" value="97" lower_limit="94" upper_limit="99"/>
                    <measurement group_id="O8" value="45" lower_limit="35" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254-mo 7 N=86,172,95,187,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O2" value="67" lower_limit="60" upper_limit="74"/>
                    <measurement group_id="O3" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O4" value="85" lower_limit="79" upper_limit="90"/>
                    <measurement group_id="O5" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O6" value="94" lower_limit="89" upper_limit="97"/>
                    <measurement group_id="O7" value="95" lower_limit="92" upper_limit="98"/>
                    <measurement group_id="O8" value="93" lower_limit="85" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With hSBA Titer ≥1:8 After Primary and Booster Vaccination.</title>
        <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titer ≥1:8 against 44/76-SL, 5/99, NZ98/254 strains.</description>
        <time_frame>at baseline, month-1, month-2, month-3, month-6 and month-7.</time_frame>
        <population>Analysis was performed as per the protocol dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With hSBA Titer ≥1:8 After Primary and Booster Vaccination.</title>
          <description>Immunogenicity was evaluated by measuring the percentage of subjects with hSBA titer ≥1:8 against 44/76-SL, 5/99, NZ98/254 strains.</description>
          <population>Analysis was performed as per the protocol dataset.</population>
          <units>percentage of Subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="223"/>
                <count group_id="O3" value="113"/>
                <count group_id="O4" value="231"/>
                <count group_id="O5" value="110"/>
                <count group_id="O6" value="232"/>
                <count group_id="O7" value="334"/>
                <count group_id="O8" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>44/76-SL- Mo 0 N=112,223,113,231,110,232,334,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="21" upper_limit="39"/>
                    <measurement group_id="O2" value="37" lower_limit="31" upper_limit="44"/>
                    <measurement group_id="O3" value="31" lower_limit="23" upper_limit="40"/>
                    <measurement group_id="O4" value="32" lower_limit="26" upper_limit="38"/>
                    <measurement group_id="O5" value="30" lower_limit="22" upper_limit="39"/>
                    <measurement group_id="O6" value="35" lower_limit="29" upper_limit="42"/>
                    <measurement group_id="O7" value="33" lower_limit="28" upper_limit="38"/>
                    <measurement group_id="O8" value="33" lower_limit="24" upper_limit="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 1 N=112,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87" lower_limit="79" upper_limit="92"/>
                    <measurement group_id="O2" value="87" lower_limit="82" upper_limit="91"/>
                    <measurement group_id="O3" value="85" lower_limit="77" upper_limit="91"/>
                    <measurement group_id="O4" value="85" lower_limit="80" upper_limit="89"/>
                    <measurement group_id="O5" value="81" lower_limit="72" upper_limit="88"/>
                    <measurement group_id="O6" value="87" lower_limit="82" upper_limit="91"/>
                    <measurement group_id="O7" value="86" lower_limit="82" upper_limit="90"/>
                    <measurement group_id="O8" value="30" lower_limit="22" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 2 N=108,213,108,222,105,219,307,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="70" upper_limit="86"/>
                    <measurement group_id="O2" value="84" lower_limit="78" upper_limit="89"/>
                    <measurement group_id="O3" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O4" value="99" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O5" value="80" lower_limit="71" upper_limit="87"/>
                    <measurement group_id="O6" value="80" lower_limit="74" upper_limit="85"/>
                    <measurement group_id="O7" value="99" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O8" value="33" lower_limit="24" upper_limit="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 3 N=107,208,105,215,104,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74" lower_limit="64" upper_limit="82"/>
                    <measurement group_id="O2" value="77" lower_limit="71" upper_limit="83"/>
                    <measurement group_id="O3" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O4" value="98" lower_limit="95" upper_limit="99"/>
                    <measurement group_id="O5" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O6" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O7" value="99" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O8" value="36" lower_limit="27" upper_limit="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 6 N= 100,188,100,198,99,201,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" lower_limit="52" upper_limit="72"/>
                    <measurement group_id="O2" value="62" lower_limit="54" upper_limit="69"/>
                    <measurement group_id="O3" value="90" lower_limit="82" upper_limit="95"/>
                    <measurement group_id="O4" value="83" lower_limit="77" upper_limit="88"/>
                    <measurement group_id="O5" value="90" lower_limit="82" upper_limit="95"/>
                    <measurement group_id="O6" value="91" lower_limit="86" upper_limit="95"/>
                    <measurement group_id="O7" value="93" lower_limit="90" upper_limit="96"/>
                    <measurement group_id="O8" value="34" lower_limit="25" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL- Mo 7 N=86,173,95,186,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="94" upper_limit="100"/>
                    <measurement group_id="O2" value="57" lower_limit="49" upper_limit="64"/>
                    <measurement group_id="O3" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O4" value="82" lower_limit="75" upper_limit="87"/>
                    <measurement group_id="O5" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O6" value="88" lower_limit="82" upper_limit="92"/>
                    <measurement group_id="O7" value="91" lower_limit="86" upper_limit="94"/>
                    <measurement group_id="O8" value="89" lower_limit="81" upper_limit="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 0 N=112,223,113,231,110,232,334,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="11" upper_limit="26"/>
                    <measurement group_id="O2" value="24" lower_limit="19" upper_limit="30"/>
                    <measurement group_id="O3" value="20" lower_limit="13" upper_limit="29"/>
                    <measurement group_id="O4" value="22" lower_limit="17" upper_limit="28"/>
                    <measurement group_id="O5" value="23" lower_limit="15" upper_limit="32"/>
                    <measurement group_id="O6" value="22" lower_limit="17" upper_limit="28"/>
                    <measurement group_id="O7" value="22" lower_limit="17" upper_limit="26"/>
                    <measurement group_id="O8" value="14" lower_limit="8" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 1 N= 111,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" lower_limit="91" upper_limit="99"/>
                    <measurement group_id="O2" value="91" lower_limit="87" upper_limit="95"/>
                    <measurement group_id="O3" value="89" lower_limit="82" upper_limit="94"/>
                    <measurement group_id="O4" value="94" lower_limit="90" upper_limit="96"/>
                    <measurement group_id="O5" value="91" lower_limit="84" upper_limit="96"/>
                    <measurement group_id="O6" value="93" lower_limit="89" upper_limit="96"/>
                    <measurement group_id="O7" value="94" lower_limit="91" upper_limit="96"/>
                    <measurement group_id="O8" value="19" lower_limit="12" upper_limit="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 2 N=108,213,108,222,105,219,308,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89" lower_limit="81" upper_limit="94"/>
                    <measurement group_id="O2" value="85" lower_limit="80" upper_limit="90"/>
                    <measurement group_id="O3" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O4" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O5" value="78" lower_limit="69" upper_limit="86"/>
                    <measurement group_id="O6" value="88" lower_limit="83" upper_limit="92"/>
                    <measurement group_id="O7" value="99" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O8" value="17" lower_limit="11" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 3 N=107,209,105,215,105,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="73" upper_limit="88"/>
                    <measurement group_id="O2" value="77" lower_limit="71" upper_limit="83"/>
                    <measurement group_id="O3" value="99" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O4" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O5" value="98" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O6" value="100" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O7" value="100" lower_limit="99" upper_limit="100"/>
                    <measurement group_id="O8" value="19" lower_limit="12" upper_limit="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 6 N=100,188,100,198,99,201,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="50" upper_limit="70"/>
                    <measurement group_id="O2" value="57" lower_limit="50" upper_limit="64"/>
                    <measurement group_id="O3" value="97" lower_limit="91" upper_limit="99"/>
                    <measurement group_id="O4" value="98" lower_limit="95" upper_limit="99"/>
                    <measurement group_id="O5" value="98" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O6" value="99" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O7" value="99" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O8" value="16" lower_limit="9" upper_limit="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 7 N=86,173,95,187,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="94" upper_limit="100"/>
                    <measurement group_id="O2" value="48" lower_limit="40" upper_limit="56"/>
                    <measurement group_id="O3" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O4" value="97" lower_limit="93" upper_limit="99"/>
                    <measurement group_id="O5" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O6" value="97" lower_limit="94" upper_limit="99"/>
                    <measurement group_id="O7" value="98" lower_limit="95" upper_limit="99"/>
                    <measurement group_id="O8" value="86" lower_limit="78" upper_limit="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 0 N=112,223,113,231,110,232,333,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" lower_limit="15" upper_limit="31"/>
                    <measurement group_id="O2" value="30" lower_limit="24" upper_limit="36"/>
                    <measurement group_id="O3" value="27" lower_limit="19" upper_limit="36"/>
                    <measurement group_id="O4" value="25" lower_limit="20" upper_limit="31"/>
                    <measurement group_id="O5" value="24" lower_limit="16" upper_limit="33"/>
                    <measurement group_id="O6" value="26" lower_limit="21" upper_limit="32"/>
                    <measurement group_id="O7" value="25" lower_limit="20" upper_limit="30"/>
                    <measurement group_id="O8" value="29" lower_limit="21" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 1 N=111,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" lower_limit="76" upper_limit="90"/>
                    <measurement group_id="O2" value="83" lower_limit="77" upper_limit="87"/>
                    <measurement group_id="O3" value="82" lower_limit="74" upper_limit="89"/>
                    <measurement group_id="O4" value="84" lower_limit="79" upper_limit="88"/>
                    <measurement group_id="O5" value="75" lower_limit="65" upper_limit="82"/>
                    <measurement group_id="O6" value="80" lower_limit="74" upper_limit="85"/>
                    <measurement group_id="O7" value="86" lower_limit="81" upper_limit="89"/>
                    <measurement group_id="O8" value="26" lower_limit="18" upper_limit="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 2 N=107,213,108,222,105,218,308,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72" lower_limit="62" upper_limit="80"/>
                    <measurement group_id="O2" value="70" lower_limit="64" upper_limit="76"/>
                    <measurement group_id="O3" value="98" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O4" value="99" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O5" value="65" lower_limit="55" upper_limit="74"/>
                    <measurement group_id="O6" value="75" lower_limit="68" upper_limit="80"/>
                    <measurement group_id="O7" value="99" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O8" value="31" lower_limit="23" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 3 N=107,208,105,215,104,215,302,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" lower_limit="60" upper_limit="79"/>
                    <measurement group_id="O2" value="65" lower_limit="58" upper_limit="71"/>
                    <measurement group_id="O3" value="90" lower_limit="82" upper_limit="95"/>
                    <measurement group_id="O4" value="91" lower_limit="86" upper_limit="94"/>
                    <measurement group_id="O5" value="98" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O6" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O7" value="98" lower_limit="96" upper_limit="99"/>
                    <measurement group_id="O8" value="30" lower_limit="21" upper_limit="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 6 N=99,188,100,198,99,200,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="49" upper_limit="69"/>
                    <measurement group_id="O2" value="54" lower_limit="47" upper_limit="62"/>
                    <measurement group_id="O3" value="80" lower_limit="71" upper_limit="87"/>
                    <measurement group_id="O4" value="77" lower_limit="70" upper_limit="82"/>
                    <measurement group_id="O5" value="86" lower_limit="77" upper_limit="92"/>
                    <measurement group_id="O6" value="86" lower_limit="80" upper_limit="90"/>
                    <measurement group_id="O7" value="91" lower_limit="87" upper_limit="94"/>
                    <measurement group_id="O8" value="38" lower_limit="28" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 7 N=86,172,95,187,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="94" upper_limit="100"/>
                    <measurement group_id="O2" value="49" lower_limit="42" upper_limit="57"/>
                    <measurement group_id="O3" value="99" lower_limit="94" upper_limit="100"/>
                    <measurement group_id="O4" value="71" lower_limit="64" upper_limit="78"/>
                    <measurement group_id="O5" value="100" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O6" value="81" lower_limit="74" upper_limit="86"/>
                    <measurement group_id="O7" value="84" lower_limit="79" upper_limit="88"/>
                    <measurement group_id="O8" value="86" lower_limit="78" upper_limit="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentages of Subjects With at Least a Fourfold Rise in hSBA Titer Over the Prevaccination and After Booster Vaccination.</title>
        <description>Immunogenicity was evaluated by measuring the percentage of subjects with at least a fourfold rise in hSBA titer over the prevaccination and after booster vaccination against 44/76-SL, 5/99, NZ98/254 strains at month-1, month-2, month-3 and month-7.</description>
        <time_frame>Month-1, month-2, month-3 and month-7</time_frame>
        <population>Analysis was performed as per the protocol dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentages of Subjects With at Least a Fourfold Rise in hSBA Titer Over the Prevaccination and After Booster Vaccination.</title>
          <description>Immunogenicity was evaluated by measuring the percentage of subjects with at least a fourfold rise in hSBA titer over the prevaccination and after booster vaccination against 44/76-SL, 5/99, NZ98/254 strains at month-1, month-2, month-3 and month-7.</description>
          <population>Analysis was performed as per the protocol dataset.</population>
          <units>percentage of Subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="223"/>
                <count group_id="O3" value="113"/>
                <count group_id="O4" value="231"/>
                <count group_id="O5" value="110"/>
                <count group_id="O6" value="232"/>
                <count group_id="O7" value="333"/>
                <count group_id="O8" value="115"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>44/76-SL Mo 1 N = 112,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73" lower_limit="64" upper_limit="81"/>
                    <measurement group_id="O2" value="75" lower_limit="69" upper_limit="80"/>
                    <measurement group_id="O3" value="71" lower_limit="61" upper_limit="79"/>
                    <measurement group_id="O4" value="77" lower_limit="71" upper_limit="82"/>
                    <measurement group_id="O5" value="67" lower_limit="58" upper_limit="76"/>
                    <measurement group_id="O6" value="73" lower_limit="67" upper_limit="79"/>
                    <measurement group_id="O7" value="72" lower_limit="67" upper_limit="77"/>
                    <measurement group_id="O8" value="3" lower_limit="1" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL Mo 2 N = 108,213,107,222,105,219,307,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" lower_limit="52" upper_limit="71"/>
                    <measurement group_id="O2" value="67" lower_limit="60" upper_limit="73"/>
                    <measurement group_id="O3" value="94" lower_limit="88" upper_limit="98"/>
                    <measurement group_id="O4" value="96" lower_limit="92" upper_limit="98"/>
                    <measurement group_id="O5" value="65" lower_limit="55" upper_limit="74"/>
                    <measurement group_id="O6" value="61" lower_limit="54" upper_limit="67"/>
                    <measurement group_id="O7" value="94" lower_limit="91" upper_limit="97"/>
                    <measurement group_id="O8" value="6" lower_limit="2" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL Mo 3 N = 107,208,104,215,104,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" lower_limit="43" upper_limit="63"/>
                    <measurement group_id="O2" value="59" lower_limit="52" upper_limit="66"/>
                    <measurement group_id="O3" value="88" lower_limit="81" upper_limit="94"/>
                    <measurement group_id="O4" value="91" lower_limit="87" upper_limit="95"/>
                    <measurement group_id="O5" value="91" lower_limit="84" upper_limit="96"/>
                    <measurement group_id="O6" value="95" lower_limit="92" upper_limit="98"/>
                    <measurement group_id="O7" value="95" lower_limit="92" upper_limit="97"/>
                    <measurement group_id="O8" value="3" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76-SL Mo 7 N = 86,173,94,186,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="89" upper_limit="99"/>
                    <measurement group_id="O2" value="33" lower_limit="26" upper_limit="40"/>
                    <measurement group_id="O3" value="98" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O4" value="73" lower_limit="66" upper_limit="79"/>
                    <measurement group_id="O5" value="93" lower_limit="86" upper_limit="98"/>
                    <measurement group_id="O6" value="76" lower_limit="69" upper_limit="82"/>
                    <measurement group_id="O7" value="80" lower_limit="75" upper_limit="85"/>
                    <measurement group_id="O8" value="76" lower_limit="66" upper_limit="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 Mo 1 N = 111,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87" lower_limit="80" upper_limit="93"/>
                    <measurement group_id="O2" value="79" lower_limit="73" upper_limit="84"/>
                    <measurement group_id="O3" value="81" lower_limit="72" upper_limit="87"/>
                    <measurement group_id="O4" value="85" lower_limit="80" upper_limit="89"/>
                    <measurement group_id="O5" value="79" lower_limit="70" upper_limit="86"/>
                    <measurement group_id="O6" value="85" lower_limit="80" upper_limit="89"/>
                    <measurement group_id="O7" value="85" lower_limit="80" upper_limit="88"/>
                    <measurement group_id="O8" value="3" lower_limit="1" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 Mo 2 N = 108,213,107,222,105,219,308,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78" lower_limit="69" upper_limit="85"/>
                    <measurement group_id="O2" value="65" lower_limit="58" upper_limit="72"/>
                    <measurement group_id="O3" value="98" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O4" value="98" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O5" value="63" lower_limit="53" upper_limit="72"/>
                    <measurement group_id="O6" value="74" lower_limit="68" upper_limit="80"/>
                    <measurement group_id="O7" value="98" lower_limit="96" upper_limit="99"/>
                    <measurement group_id="O8" value="5" lower_limit="2" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 Mo 3 N=107,209,104,215,105,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" lower_limit="56" upper_limit="74"/>
                    <measurement group_id="O2" value="53" lower_limit="46" upper_limit="60"/>
                    <measurement group_id="O3" value="95" lower_limit="89" upper_limit="98"/>
                    <measurement group_id="O4" value="99" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O5" value="96" lower_limit="91" upper_limit="99"/>
                    <measurement group_id="O6" value="99" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O7" value="99" lower_limit="98" upper_limit="100"/>
                    <measurement group_id="O8" value="6" lower_limit="3" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99- Mo 7 N = 86,173,94,187,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O2" value="27" lower_limit="21" upper_limit="34"/>
                    <measurement group_id="O3" value="99" lower_limit="94" upper_limit="100"/>
                    <measurement group_id="O4" value="88" lower_limit="82" upper_limit="92"/>
                    <measurement group_id="O5" value="99" lower_limit="94" upper_limit="100"/>
                    <measurement group_id="O6" value="90" lower_limit="85" upper_limit="94"/>
                    <measurement group_id="O7" value="94" lower_limit="90" upper_limit="97"/>
                    <measurement group_id="O8" value="82" lower_limit="73" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 1 N = 111,223,113,231,110,232,332,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72" lower_limit="63" upper_limit="80"/>
                    <measurement group_id="O2" value="70" lower_limit="63" upper_limit="76"/>
                    <measurement group_id="O3" value="65" lower_limit="56" upper_limit="74"/>
                    <measurement group_id="O4" value="74" lower_limit="67" upper_limit="79"/>
                    <measurement group_id="O5" value="59" lower_limit="49" upper_limit="68"/>
                    <measurement group_id="O6" value="64" lower_limit="58" upper_limit="70"/>
                    <measurement group_id="O7" value="73" lower_limit="68" upper_limit="78"/>
                    <measurement group_id="O8" value="3" lower_limit="1" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 2 N = 107,213,107,222,105,218,307,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57" lower_limit="47" upper_limit="67"/>
                    <measurement group_id="O2" value="52" lower_limit="45" upper_limit="59"/>
                    <measurement group_id="O3" value="89" lower_limit="81" upper_limit="94"/>
                    <measurement group_id="O4" value="93" lower_limit="89" upper_limit="96"/>
                    <measurement group_id="O5" value="51" lower_limit="41" upper_limit="61"/>
                    <measurement group_id="O6" value="57" lower_limit="50" upper_limit="64"/>
                    <measurement group_id="O7" value="93" lower_limit="89" upper_limit="95"/>
                    <measurement group_id="O8" value="7" lower_limit="3" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 3 N = 107,208,104,215,104,215,301,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" lower_limit="40" upper_limit="59"/>
                    <measurement group_id="O2" value="43" lower_limit="36" upper_limit="50"/>
                    <measurement group_id="O3" value="78" lower_limit="69" upper_limit="85"/>
                    <measurement group_id="O4" value="81" lower_limit="76" upper_limit="86"/>
                    <measurement group_id="O5" value="91" lower_limit="84" upper_limit="96"/>
                    <measurement group_id="O6" value="91" lower_limit="86" upper_limit="94"/>
                    <measurement group_id="O7" value="93" lower_limit="90" upper_limit="96"/>
                    <measurement group_id="O8" value="6" lower_limit="3" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 Mo 7 N = 86,172,94,187,91,179,254,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="87" upper_limit="98"/>
                    <measurement group_id="O2" value="27" lower_limit="21" upper_limit="35"/>
                    <measurement group_id="O3" value="95" lower_limit="88" upper_limit="98"/>
                    <measurement group_id="O4" value="62" lower_limit="55" upper_limit="69"/>
                    <measurement group_id="O5" value="92" lower_limit="85" upper_limit="97"/>
                    <measurement group_id="O6" value="69" lower_limit="62" upper_limit="76"/>
                    <measurement group_id="O7" value="75" lower_limit="69" upper_limit="80"/>
                    <measurement group_id="O8" value="77" lower_limit="67" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titers (GMTs) After Primary and Booster Vaccination.</title>
        <description>Immunogenicity was evaluated by measuring the Geometric mean titers (GMTs) after primary and booster vaccination against 44/76-SL, 5/99, NZ98/254.</description>
        <time_frame>month-1, month-2, month-3, month-6 and month-7</time_frame>
        <population>Analysis was performed as per the protocol dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titers (GMTs) After Primary and Booster Vaccination.</title>
          <description>Immunogenicity was evaluated by measuring the Geometric mean titers (GMTs) after primary and booster vaccination against 44/76-SL, 5/99, NZ98/254.</description>
          <population>Analysis was performed as per the protocol dataset.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="223"/>
                <count group_id="O3" value="113"/>
                <count group_id="O4" value="231"/>
                <count group_id="O5" value="110"/>
                <count group_id="O6" value="232"/>
                <count group_id="O7" value="334"/>
                <count group_id="O8" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>44/76 GMT Mo 0 N=112,223,113,231,110,232,334,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.41" lower_limit="2.54" upper_limit="4.58"/>
                    <measurement group_id="O2" value="4.24" lower_limit="3.44" upper_limit="5.22"/>
                    <measurement group_id="O3" value="3.34" lower_limit="2.49" upper_limit="4.48"/>
                    <measurement group_id="O4" value="3.35" lower_limit="2.72" upper_limit="4.11"/>
                    <measurement group_id="O5" value="3.39" lower_limit="2.52" upper_limit="4.56"/>
                    <measurement group_id="O6" value="3.99" lower_limit="3.25" upper_limit="4.9"/>
                    <measurement group_id="O7" value="3.87" lower_limit="3.26" upper_limit="4.6"/>
                    <measurement group_id="O8" value="3.89" lower_limit="2.91" upper_limit="5.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76 GMT Mo 1 N=112,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" lower_limit="33" upper_limit="63"/>
                    <measurement group_id="O2" value="58" lower_limit="46" upper_limit="72"/>
                    <measurement group_id="O3" value="56" lower_limit="40" upper_limit="77"/>
                    <measurement group_id="O4" value="52" lower_limit="41" upper_limit="65"/>
                    <measurement group_id="O5" value="44" lower_limit="32" upper_limit="61"/>
                    <measurement group_id="O6" value="57" lower_limit="45" upper_limit="71"/>
                    <measurement group_id="O7" value="60" lower_limit="49" upper_limit="72"/>
                    <measurement group_id="O8" value="3.39" lower_limit="2.46" upper_limit="4.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76 GMT Mo 2 N = 108,213,108,222,105,219,307,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31" lower_limit="23" upper_limit="41"/>
                    <measurement group_id="O2" value="41" lower_limit="34" upper_limit="50"/>
                    <measurement group_id="O3" value="182" lower_limit="138" upper_limit="240"/>
                    <measurement group_id="O4" value="187" lower_limit="154" upper_limit="228"/>
                    <measurement group_id="O5" value="28" lower_limit="21" upper_limit="37"/>
                    <measurement group_id="O6" value="38" lower_limit="31" upper_limit="46"/>
                    <measurement group_id="O7" value="193" lower_limit="164" upper_limit="228"/>
                    <measurement group_id="O8" value="4.09" lower_limit="3.11" upper_limit="5.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76 GMT Mo 3 N = 107,208,105,215,104,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="16" upper_limit="26"/>
                    <measurement group_id="O2" value="31" lower_limit="26" upper_limit="38"/>
                    <measurement group_id="O3" value="132" lower_limit="101" upper_limit="172"/>
                    <measurement group_id="O4" value="114" lower_limit="95" upper_limit="137"/>
                    <measurement group_id="O5" value="182" lower_limit="139" upper_limit="236"/>
                    <measurement group_id="O6" value="230" lower_limit="191" upper_limit="277"/>
                    <measurement group_id="O7" value="240" lower_limit="205" upper_limit="280"/>
                    <measurement group_id="O8" value="4.04" lower_limit="3.12" upper_limit="5.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76 GMT Mo 6 N= 100,188,100,198,99,201,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="9.24" upper_limit="18"/>
                    <measurement group_id="O2" value="15" lower_limit="12" upper_limit="19"/>
                    <measurement group_id="O3" value="59" lower_limit="43" upper_limit="82"/>
                    <measurement group_id="O4" value="50" lower_limit="39" upper_limit="63"/>
                    <measurement group_id="O5" value="54" lower_limit="39" upper_limit="75"/>
                    <measurement group_id="O6" value="75" lower_limit="60" upper_limit="95"/>
                    <measurement group_id="O7" value="86" lower_limit="70" upper_limit="104"/>
                    <measurement group_id="O8" value="3.9" lower_limit="2.82" upper_limit="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76 GMT Mo 7 N= 86,173,95,186,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="218" lower_limit="157" upper_limit="302"/>
                    <measurement group_id="O2" value="12" lower_limit="9.69" upper_limit="15"/>
                    <measurement group_id="O3" value="324" lower_limit="236" upper_limit="443"/>
                    <measurement group_id="O4" value="36" lower_limit="29" upper_limit="45"/>
                    <measurement group_id="O5" value="259" lower_limit="188" upper_limit="357"/>
                    <measurement group_id="O6" value="48" lower_limit="38" upper_limit="60"/>
                    <measurement group_id="O7" value="59" lower_limit="49" upper_limit="72"/>
                    <measurement group_id="O8" value="56" lower_limit="41" upper_limit="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 GMT Mo 0 N= 112,223,113,231,110,232,334,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.61" lower_limit="2.03" upper_limit="3.34"/>
                    <measurement group_id="O2" value="3.15" lower_limit="2.64" upper_limit="3.75"/>
                    <measurement group_id="O3" value="2.59" lower_limit="2.02" upper_limit="3.32"/>
                    <measurement group_id="O4" value="2.52" lower_limit="2.11" upper_limit="2.99"/>
                    <measurement group_id="O5" value="2.43" lower_limit="1.89" upper_limit="3.12"/>
                    <measurement group_id="O6" value="2.72" lower_limit="2.29" upper_limit="3.24"/>
                    <measurement group_id="O7" value="2.58" lower_limit="2.23" upper_limit="2.98"/>
                    <measurement group_id="O8" value="2.27" lower_limit="1.78" upper_limit="2.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 GMT Mo 1 N= 111,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="61" upper_limit="109"/>
                    <measurement group_id="O2" value="64" lower_limit="52" upper_limit="79"/>
                    <measurement group_id="O3" value="66" lower_limit="49" upper_limit="88"/>
                    <measurement group_id="O4" value="72" lower_limit="59" upper_limit="88"/>
                    <measurement group_id="O5" value="57" lower_limit="42" upper_limit="76"/>
                    <measurement group_id="O6" value="76" lower_limit="62" upper_limit="93"/>
                    <measurement group_id="O7" value="71" lower_limit="60" upper_limit="84"/>
                    <measurement group_id="O8" value="2.56" lower_limit="1.93" upper_limit="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 GMT Mo 2 N= 108,213,108,222,105,219,308,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40" lower_limit="31" upper_limit="51"/>
                    <measurement group_id="O2" value="34" lower_limit="28" upper_limit="40"/>
                    <measurement group_id="O3" value="505" lower_limit="396" upper_limit="644"/>
                    <measurement group_id="O4" value="451" lower_limit="381" upper_limit="535"/>
                    <measurement group_id="O5" value="26" lower_limit="20" upper_limit="33"/>
                    <measurement group_id="O6" value="40" lower_limit="34" upper_limit="48"/>
                    <measurement group_id="O7" value="481" lower_limit="415" upper_limit="556"/>
                    <measurement group_id="O8" value="2.48" lower_limit="1.95" upper_limit="3.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 GMT Mo 3 N= 107,209,105,215,105,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" lower_limit="20" upper_limit="31"/>
                    <measurement group_id="O2" value="23" lower_limit="20" upper_limit="27"/>
                    <measurement group_id="O3" value="303" lower_limit="242" upper_limit="380"/>
                    <measurement group_id="O4" value="273" lower_limit="233" upper_limit="320"/>
                    <measurement group_id="O5" value="540" lower_limit="431" upper_limit="677"/>
                    <measurement group_id="O6" value="822" lower_limit="702" upper_limit="964"/>
                    <measurement group_id="O7" value="584" lower_limit="510" upper_limit="668"/>
                    <measurement group_id="O8" value="2.58" lower_limit="2.07" upper_limit="3.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 GMT Mo 6 N= 100,188,100,198,99,201,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="9.56" upper_limit="16"/>
                    <measurement group_id="O2" value="11" lower_limit="9.26" upper_limit="13"/>
                    <measurement group_id="O3" value="125" lower_limit="98" upper_limit="160"/>
                    <measurement group_id="O4" value="113" lower_limit="95" upper_limit="135"/>
                    <measurement group_id="O5" value="124" lower_limit="97" upper_limit="158"/>
                    <measurement group_id="O6" value="147" lower_limit="123" upper_limit="175"/>
                    <measurement group_id="O7" value="186" lower_limit="160" upper_limit="216"/>
                    <measurement group_id="O8" value="2.03" lower_limit="1.59" upper_limit="2.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99 GMT Mo 7 N= 86,173,95,187,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="880" lower_limit="675" upper_limit="1147"/>
                    <measurement group_id="O2" value="8.61" lower_limit="7.13" upper_limit="10"/>
                    <measurement group_id="O3" value="1094" lower_limit="849" upper_limit="1410"/>
                    <measurement group_id="O4" value="99" lower_limit="82" upper_limit="119"/>
                    <measurement group_id="O5" value="994" lower_limit="767" upper_limit="1289"/>
                    <measurement group_id="O6" value="121" lower_limit="101" upper_limit="146"/>
                    <measurement group_id="O7" value="164" lower_limit="141" upper_limit="192"/>
                    <measurement group_id="O8" value="53" lower_limit="41" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254GMTMo 0 N=112,223,113,231,110,232,333,116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.87" lower_limit="2.14" upper_limit="3.84"/>
                    <measurement group_id="O2" value="3.35" lower_limit="2.72" upper_limit="4.13"/>
                    <measurement group_id="O3" value="3.43" lower_limit="2.56" upper_limit="4.59"/>
                    <measurement group_id="O4" value="2.98" lower_limit="2.43" upper_limit="3.66"/>
                    <measurement group_id="O5" value="3.07" lower_limit="2.28" upper_limit="4.12"/>
                    <measurement group_id="O6" value="3.39" lower_limit="2.76" upper_limit="4.16"/>
                    <measurement group_id="O7" value="2.83" lower_limit="2.38" upper_limit="3.36"/>
                    <measurement group_id="O8" value="3.12" lower_limit="2.34" upper_limit="4.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 GMT Mo1 N=111,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="31" upper_limit="56"/>
                    <measurement group_id="O2" value="44" lower_limit="36" upper_limit="55"/>
                    <measurement group_id="O3" value="47" lower_limit="35" upper_limit="63"/>
                    <measurement group_id="O4" value="45" lower_limit="36" upper_limit="55"/>
                    <measurement group_id="O5" value="37" lower_limit="27" upper_limit="50"/>
                    <measurement group_id="O6" value="42" lower_limit="34" upper_limit="52"/>
                    <measurement group_id="O7" value="49" lower_limit="41" upper_limit="58"/>
                    <measurement group_id="O8" value="2.85" lower_limit="2.11" upper_limit="3.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 GMT Mo2 N=107,213,108,222,105,218,308,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="17" upper_limit="30"/>
                    <measurement group_id="O2" value="25" lower_limit="20" upper_limit="31"/>
                    <measurement group_id="O3" value="98" lower_limit="72" upper_limit="132"/>
                    <measurement group_id="O4" value="89" lower_limit="72" upper_limit="110"/>
                    <measurement group_id="O5" value="19" lower_limit="14" upper_limit="26"/>
                    <measurement group_id="O6" value="26" lower_limit="21" upper_limit="32"/>
                    <measurement group_id="O7" value="92" lower_limit="77" upper_limit="110"/>
                    <measurement group_id="O8" value="3.28" lower_limit="2.43" upper_limit="4.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 GMT Mo3 N=107,208,105,215,104,215,302,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="13" upper_limit="22"/>
                    <measurement group_id="O2" value="19" lower_limit="16" upper_limit="24"/>
                    <measurement group_id="O3" value="61" lower_limit="46" upper_limit="82"/>
                    <measurement group_id="O4" value="52" lower_limit="42" upper_limit="64"/>
                    <measurement group_id="O5" value="117" lower_limit="87" upper_limit="157"/>
                    <measurement group_id="O6" value="125" lower_limit="102" upper_limit="154"/>
                    <measurement group_id="O7" value="122" lower_limit="102" upper_limit="145"/>
                    <measurement group_id="O8" value="3.57" lower_limit="2.68" upper_limit="4.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 GMT Mo 6 N=99,188,100,198,99,200,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="8.94" upper_limit="17"/>
                    <measurement group_id="O2" value="11" lower_limit="8.63" upper_limit="14"/>
                    <measurement group_id="O3" value="31" lower_limit="22" upper_limit="42"/>
                    <measurement group_id="O4" value="29" lower_limit="23" upper_limit="36"/>
                    <measurement group_id="O5" value="44" lower_limit="32" upper_limit="61"/>
                    <measurement group_id="O6" value="49" lower_limit="39" upper_limit="61"/>
                    <measurement group_id="O7" value="52" lower_limit="43" upper_limit="63"/>
                    <measurement group_id="O8" value="4.17" lower_limit="3.04" upper_limit="5.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254 GMT Mo 7 N= 86,172,95,187,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140" lower_limit="101" upper_limit="195"/>
                    <measurement group_id="O2" value="10" lower_limit="8.01" upper_limit="13"/>
                    <measurement group_id="O3" value="181" lower_limit="132" upper_limit="248"/>
                    <measurement group_id="O4" value="24" lower_limit="19" upper_limit="30"/>
                    <measurement group_id="O5" value="168" lower_limit="122" upper_limit="232"/>
                    <measurement group_id="O6" value="39" lower_limit="31" upper_limit="49"/>
                    <measurement group_id="O7" value="41" lower_limit="34" upper_limit="50"/>
                    <measurement group_id="O8" value="47" lower_limit="34" upper_limit="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Ratios (GMRs) After Primary and Booster Vaccination.</title>
        <description>Immunogenicity was evaluated by measuring the Geometric mean ratios (GMRs) after primary and booster vaccination against 44/76-SL, 5/99, NZ98/254.</description>
        <time_frame>month-1, month-2, month-3, month-6 and month-7</time_frame>
        <population>Analysis was performed as per the protocol dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Ratios (GMRs) After Primary and Booster Vaccination.</title>
          <description>Immunogenicity was evaluated by measuring the Geometric mean ratios (GMRs) after primary and booster vaccination against 44/76-SL, 5/99, NZ98/254.</description>
          <population>Analysis was performed as per the protocol dataset.</population>
          <units>Ratio</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="223"/>
                <count group_id="O3" value="113"/>
                <count group_id="O4" value="231"/>
                <count group_id="O5" value="110"/>
                <count group_id="O6" value="232"/>
                <count group_id="O7" value="333"/>
                <count group_id="O8" value="115"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>44/76GMR Mo 1to0 N=112,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="10" upper_limit="18"/>
                    <measurement group_id="O2" value="14" lower_limit="11" upper_limit="17"/>
                    <measurement group_id="O3" value="17" lower_limit="12" upper_limit="22"/>
                    <measurement group_id="O4" value="16" lower_limit="13" upper_limit="19"/>
                    <measurement group_id="O5" value="13" lower_limit="9.71" upper_limit="18"/>
                    <measurement group_id="O6" value="14" lower_limit="12" upper_limit="17"/>
                    <measurement group_id="O7" value="15" lower_limit="13" upper_limit="18"/>
                    <measurement group_id="O8" value="0.89" lower_limit="0.66" upper_limit="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76GMR Mo 2to0 N=108,213,107,222,105,219,307,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.92" lower_limit="6.73" upper_limit="12"/>
                    <measurement group_id="O2" value="9.65" lower_limit="7.88" upper_limit="12"/>
                    <measurement group_id="O3" value="53" lower_limit="40" upper_limit="71"/>
                    <measurement group_id="O4" value="56" lower_limit="46" upper_limit="69"/>
                    <measurement group_id="O5" value="8.43" lower_limit="6.33" upper_limit="11"/>
                    <measurement group_id="O6" value="9.51" lower_limit="7.79" upper_limit="12"/>
                    <measurement group_id="O7" value="50" lower_limit="42" upper_limit="59"/>
                    <measurement group_id="O8" value="1.04" lower_limit="0.79" upper_limit="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76GMR Mo 3to0 N=107,208,104,215,104,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.98" lower_limit="4.51" upper_limit="7.92"/>
                    <measurement group_id="O2" value="7.31" lower_limit="5.97" upper_limit="8.96"/>
                    <measurement group_id="O3" value="37" lower_limit="28" upper_limit="50"/>
                    <measurement group_id="O4" value="34" lower_limit="28" upper_limit="42"/>
                    <measurement group_id="O5" value="55" lower_limit="41" upper_limit="73"/>
                    <measurement group_id="O6" value="58" lower_limit="48" upper_limit="71"/>
                    <measurement group_id="O7" value="62" lower_limit="52" upper_limit="73"/>
                    <measurement group_id="O8" value="0.98" lower_limit="0.74" upper_limit="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76GMR Mo 6to0 N=100,188,99,198,99,201,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.98" lower_limit="2.96" upper_limit="5.35"/>
                    <measurement group_id="O2" value="3.64" lower_limit="2.93" upper_limit="4.52"/>
                    <measurement group_id="O3" value="17" lower_limit="13" upper_limit="23"/>
                    <measurement group_id="O4" value="16" lower_limit="13" upper_limit="19"/>
                    <measurement group_id="O5" value="16" lower_limit="12" upper_limit="21"/>
                    <measurement group_id="O6" value="20" lower_limit="16" upper_limit="25"/>
                    <measurement group_id="O7" value="23" lower_limit="19" upper_limit="27"/>
                    <measurement group_id="O8" value="0.92" lower_limit="0.69" upper_limit="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76GMR Mo 7to0 N=86,173,94,186,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74" lower_limit="54" upper_limit="103"/>
                    <measurement group_id="O2" value="3.09" lower_limit="2.46" upper_limit="3.88"/>
                    <measurement group_id="O3" value="92" lower_limit="67" upper_limit="125"/>
                    <measurement group_id="O4" value="12" lower_limit="9.24" upper_limit="14"/>
                    <measurement group_id="O5" value="79" lower_limit="58" upper_limit="109"/>
                    <measurement group_id="O6" value="13" lower_limit="11" upper_limit="17"/>
                    <measurement group_id="O7" value="16" lower_limit="13" upper_limit="19"/>
                    <measurement group_id="O8" value="13" lower_limit="9.76" upper_limit="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44/76GMR Mo 7to6 N=86,173,95,186,91,179,255,94</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="14" upper_limit="23"/>
                    <measurement group_id="O2" value="0.89" lower_limit="0.76" upper_limit="1.05"/>
                    <measurement group_id="O3" value="5.36" lower_limit="4.3" upper_limit="6.68"/>
                    <measurement group_id="O4" value="0.72" lower_limit="0.61" upper_limit="0.84"/>
                    <measurement group_id="O5" value="5.08" lower_limit="4.05" upper_limit="6.37"/>
                    <measurement group_id="O6" value="0.67" lower_limit="0.57" upper_limit="0.79"/>
                    <measurement group_id="O7" value="0.67" lower_limit="0.59" upper_limit="0.77"/>
                    <measurement group_id="O8" value="14" lower_limit="11" upper_limit="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99GMR Mo 1to0 N=111,223,113,231,110,232,333,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31" lower_limit="23" upper_limit="42"/>
                    <measurement group_id="O2" value="20" lower_limit="16" upper_limit="25"/>
                    <measurement group_id="O3" value="25" lower_limit="19" upper_limit="34"/>
                    <measurement group_id="O4" value="29" lower_limit="23" upper_limit="35"/>
                    <measurement group_id="O5" value="23" lower_limit="17" upper_limit="32"/>
                    <measurement group_id="O6" value="28" lower_limit="23" upper_limit="34"/>
                    <measurement group_id="O7" value="28" lower_limit="23" upper_limit="33"/>
                    <measurement group_id="O8" value="1.13" lower_limit="0.84" upper_limit="1.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99GMR Mo 2to0 N=108,213,107,222,105,219,308,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="11" upper_limit="20"/>
                    <measurement group_id="O2" value="11" lower_limit="8.65" upper_limit="13"/>
                    <measurement group_id="O3" value="198" lower_limit="149" upper_limit="262"/>
                    <measurement group_id="O4" value="181" lower_limit="149" upper_limit="220"/>
                    <measurement group_id="O5" value="11" lower_limit="8.13" upper_limit="14"/>
                    <measurement group_id="O6" value="15" lower_limit="12" upper_limit="18"/>
                    <measurement group_id="O7" value="186" lower_limit="158" upper_limit="220"/>
                    <measurement group_id="O8" value="1.06" lower_limit="0.8" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99GMR Mo 3to0 N=107,209,104,215,105,215,303,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.22" lower_limit="6.94" upper_limit="12"/>
                    <measurement group_id="O2" value="7.37" lower_limit="6.01" upper_limit="9.04"/>
                    <measurement group_id="O3" value="115" lower_limit="86" upper_limit="153"/>
                    <measurement group_id="O4" value="109" lower_limit="89" upper_limit="133"/>
                    <measurement group_id="O5" value="233" lower_limit="175" upper_limit="311"/>
                    <measurement group_id="O6" value="306" lower_limit="250" upper_limit="374"/>
                    <measurement group_id="O7" value="225" lower_limit="190" upper_limit="267"/>
                    <measurement group_id="O8" value="1.09" lower_limit="0.82" upper_limit="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99GMR Mo 6to0 N=100,188,99,198,99,201,278,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.65" lower_limit="3.47" upper_limit="6.23"/>
                    <measurement group_id="O2" value="3.83" lower_limit="3.09" upper_limit="4.75"/>
                    <measurement group_id="O3" value="49" lower_limit="37" upper_limit="66"/>
                    <measurement group_id="O4" value="45" lower_limit="36" upper_limit="55"/>
                    <measurement group_id="O5" value="52" lower_limit="39" upper_limit="70"/>
                    <measurement group_id="O6" value="56" lower_limit="45" upper_limit="69"/>
                    <measurement group_id="O7" value="74" lower_limit="62" upper_limit="88"/>
                    <measurement group_id="O8" value="0.82" lower_limit="0.61" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99GMR Mo 7 to 0 N=86,173,94,187,91,179,255,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="355" lower_limit="254" upper_limit="497"/>
                    <measurement group_id="O2" value="3.07" lower_limit="2.42" upper_limit="3.89"/>
                    <measurement group_id="O3" value="430" lower_limit="312" upper_limit="594"/>
                    <measurement group_id="O4" value="40" lower_limit="32" upper_limit="50"/>
                    <measurement group_id="O5" value="427" lower_limit="307" upper_limit="593"/>
                    <measurement group_id="O6" value="46" lower_limit="36" upper_limit="58"/>
                    <measurement group_id="O7" value="65" lower_limit="53" upper_limit="79"/>
                    <measurement group_id="O8" value="21" lower_limit="16" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5/99GMR Mo 7to6 N=86,173,95,187,91,179,255,94</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" lower_limit="55" upper_limit="90"/>
                    <measurement group_id="O2" value="0.83" lower_limit="0.7" upper_limit="0.99"/>
                    <measurement group_id="O3" value="8.98" lower_limit="7.13" upper_limit="11"/>
                    <measurement group_id="O4" value="0.87" lower_limit="0.74" upper_limit="1.03"/>
                    <measurement group_id="O5" value="7.92" lower_limit="6.26" upper_limit="10"/>
                    <measurement group_id="O6" value="0.83" lower_limit="0.71" upper_limit="0.99"/>
                    <measurement group_id="O7" value="0.86" lower_limit="0.74" upper_limit="0.99"/>
                    <measurement group_id="O8" value="26" lower_limit="20" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254GMR Mo 1to0 N=111,223,113,231,110,332,115</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" lower_limit="11" upper_limit="19"/>
                    <measurement group_id="O2" value="13" lower_limit="11" upper_limit="16"/>
                    <measurement group_id="O3" value="14" lower_limit="10" upper_limit="18"/>
                    <measurement group_id="O4" value="15" lower_limit="12" upper_limit="18"/>
                    <measurement group_id="O5" value="12" lower_limit="9" upper_limit="16"/>
                    <measurement group_id="O6" value="12" lower_limit="10" upper_limit="15"/>
                    <measurement group_id="O7" value="17" lower_limit="15" upper_limit="21"/>
                    <measurement group_id="O8" value="0.91" lower_limit="0.68" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254GMR Mo 2to0 N=107,213,107,222,105,307,109</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.69" lower_limit="5.86" upper_limit="10"/>
                    <measurement group_id="O2" value="7.24" lower_limit="5.97" upper_limit="8.79"/>
                    <measurement group_id="O3" value="29" lower_limit="22" upper_limit="38"/>
                    <measurement group_id="O4" value="30" lower_limit="24" upper_limit="36"/>
                    <measurement group_id="O5" value="6.46" lower_limit="4.91" upper_limit="8.5"/>
                    <measurement group_id="O6" value="7.96" lower_limit="6.57" upper_limit="9.63"/>
                    <measurement group_id="O7" value="33" lower_limit="28" upper_limit="39"/>
                    <measurement group_id="O8" value="1.06" lower_limit="0.81" upper_limit="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254GMR Mo 3to0 N=107,208,104,215,104,301,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.01" lower_limit="4.54" upper_limit="7.96"/>
                    <measurement group_id="O2" value="5.5" lower_limit="4.49" upper_limit="6.74"/>
                    <measurement group_id="O3" value="18" lower_limit="14" upper_limit="24"/>
                    <measurement group_id="O4" value="18" lower_limit="14" upper_limit="21"/>
                    <measurement group_id="O5" value="40" lower_limit="30" upper_limit="54"/>
                    <measurement group_id="O6" value="38" lower_limit="32" upper_limit="47"/>
                    <measurement group_id="O7" value="44" lower_limit="37" upper_limit="52"/>
                    <measurement group_id="O8" value="1.13" lower_limit="0.86" upper_limit="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254GMR Mo 6to0 N=99,188,99,198,99,200,277,100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.75" lower_limit="3.62" upper_limit="6.24"/>
                    <measurement group_id="O2" value="3.49" lower_limit="2.86" upper_limit="4.26"/>
                    <measurement group_id="O3" value="9.26" lower_limit="7.05" upper_limit="12"/>
                    <measurement group_id="O4" value="10" lower_limit="8.29" upper_limit="12"/>
                    <measurement group_id="O5" value="14" lower_limit="11" upper_limit="19"/>
                    <measurement group_id="O6" value="15" lower_limit="13" upper_limit="19"/>
                    <measurement group_id="O7" value="19" lower_limit="16" upper_limit="22"/>
                    <measurement group_id="O8" value="1.28" lower_limit="0.98" upper_limit="1.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254GMR Mo 7to0 N=86,172,94,187,91,179,254,95</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59" lower_limit="44" upper_limit="80"/>
                    <measurement group_id="O2" value="3.32" lower_limit="2.67" upper_limit="4.12"/>
                    <measurement group_id="O3" value="53" lower_limit="40" upper_limit="71"/>
                    <measurement group_id="O4" value="8.94" lower_limit="7.26" upper_limit="11"/>
                    <measurement group_id="O5" value="57" lower_limit="42" upper_limit="77"/>
                    <measurement group_id="O6" value="13" lower_limit="10" upper_limit="16"/>
                    <measurement group_id="O7" value="15" lower_limit="12" upper_limit="18"/>
                    <measurement group_id="O8" value="15" lower_limit="11" upper_limit="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NZ98/254GMR Mo 7to6 N=85,172,95,187,91,179,255,94</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="8.73" upper_limit="14"/>
                    <measurement group_id="O2" value="0.99" lower_limit="0.84" upper_limit="1.17"/>
                    <measurement group_id="O3" value="5.86" lower_limit="4.7" upper_limit="7.3"/>
                    <measurement group_id="O4" value="0.85" lower_limit="0.73" upper_limit="1"/>
                    <measurement group_id="O5" value="3.95" lower_limit="3.15" upper_limit="4.95"/>
                    <measurement group_id="O6" value="0.84" lower_limit="0.72" upper_limit="0.99"/>
                    <measurement group_id="O7" value="0.81" lower_limit="0.7" upper_limit="0.92"/>
                    <measurement group_id="O8" value="11" lower_limit="8.98" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GMCs of Antibodies Against 287-953Antigen (ELISA) After Primary and Booster Vaccination.</title>
        <description>Immunogenicity was evaluated by measuring the Geometric mean Concentration (GMCs) after primary and booster vaccination against Antigen 287-953 Antigen.</description>
        <time_frame>month-1, month-2, month-3, month-6 and month-7</time_frame>
        <population>Analysis was performed as per the protocol dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>GMCs of Antibodies Against 287-953Antigen (ELISA) After Primary and Booster Vaccination.</title>
          <description>Immunogenicity was evaluated by measuring the Geometric mean Concentration (GMCs) after primary and booster vaccination against Antigen 287-953 Antigen.</description>
          <population>Analysis was performed as per the protocol dataset.</population>
          <units>IU/ml</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="35"/>
                <count group_id="O4" value="35"/>
                <count group_id="O5" value="35"/>
                <count group_id="O6" value="35"/>
                <count group_id="O7" value="35"/>
                <count group_id="O8" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GMC Mo 0 N=34,35,35,32,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="25" upper_limit="51"/>
                    <measurement group_id="O2" value="35" lower_limit="25" upper_limit="50"/>
                    <measurement group_id="O3" value="43" lower_limit="30" upper_limit="61"/>
                    <measurement group_id="O4" value="37" lower_limit="26" upper_limit="54"/>
                    <measurement group_id="O5" value="44" lower_limit="31" upper_limit="63"/>
                    <measurement group_id="O6" value="32" lower_limit="23" upper_limit="46"/>
                    <measurement group_id="O7" value="32" lower_limit="22" upper_limit="45"/>
                    <measurement group_id="O8" value="48" lower_limit="34" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMC Mo 1 N=34,35,35,35,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="190" lower_limit="113" upper_limit="318"/>
                    <measurement group_id="O2" value="204" lower_limit="123" upper_limit="340"/>
                    <measurement group_id="O3" value="334" lower_limit="200" upper_limit="555"/>
                    <measurement group_id="O4" value="217" lower_limit="130" upper_limit="361"/>
                    <measurement group_id="O5" value="234" lower_limit="140" upper_limit="389"/>
                    <measurement group_id="O6" value="220" lower_limit="132" upper_limit="367"/>
                    <measurement group_id="O7" value="521" lower_limit="313" upper_limit="868"/>
                    <measurement group_id="O8" value="50" lower_limit="30" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMC Mo 2 N=34,35,35,34,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173" lower_limit="115" upper_limit="261"/>
                    <measurement group_id="O2" value="154" lower_limit="102" upper_limit="231"/>
                    <measurement group_id="O3" value="3025" lower_limit="2015" upper_limit="4543"/>
                    <measurement group_id="O4" value="3875" lower_limit="2566" upper_limit="5854"/>
                    <measurement group_id="O5" value="175" lower_limit="117" upper_limit="263"/>
                    <measurement group_id="O6" value="144" lower_limit="96" upper_limit="216"/>
                    <measurement group_id="O7" value="3693" lower_limit="2459" upper_limit="5545"/>
                    <measurement group_id="O8" value="42" lower_limit="28" upper_limit="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMC Mo 3 N=34,35,35,34,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102" lower_limit="69" upper_limit="152"/>
                    <measurement group_id="O2" value="124" lower_limit="84" upper_limit="183"/>
                    <measurement group_id="O3" value="1612" lower_limit="1093" upper_limit="2378"/>
                    <measurement group_id="O4" value="1831" lower_limit="1234" upper_limit="2716"/>
                    <measurement group_id="O5" value="3332" lower_limit="2259" upper_limit="4916"/>
                    <measurement group_id="O6" value="2936" lower_limit="1990" upper_limit="4332"/>
                    <measurement group_id="O7" value="5314" lower_limit="3602" upper_limit="7839"/>
                    <measurement group_id="O8" value="42" lower_limit="29" upper_limit="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMC Mo 6 N=34,35,35,35,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" lower_limit="59" upper_limit="138"/>
                    <measurement group_id="O2" value="72" lower_limit="48" upper_limit="110"/>
                    <measurement group_id="O3" value="565" lower_limit="372" upper_limit="857"/>
                    <measurement group_id="O4" value="488" lower_limit="322" upper_limit="741"/>
                    <measurement group_id="O5" value="807" lower_limit="531" upper_limit="1224"/>
                    <measurement group_id="O6" value="628" lower_limit="414" upper_limit="953"/>
                    <measurement group_id="O7" value="1602" lower_limit="1055" upper_limit="2431"/>
                    <measurement group_id="O8" value="37" lower_limit="24" upper_limit="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMC Mo 7 N=34,34,35,34,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2240" lower_limit="1385" upper_limit="3623"/>
                    <measurement group_id="O2" value="69" lower_limit="43" upper_limit="112"/>
                    <measurement group_id="O3" value="3840" lower_limit="2391" upper_limit="6168"/>
                    <measurement group_id="O4" value="383" lower_limit="237" upper_limit="620"/>
                    <measurement group_id="O5" value="5492" lower_limit="3419" upper_limit="8821"/>
                    <measurement group_id="O6" value="532" lower_limit="331" upper_limit="855"/>
                    <measurement group_id="O7" value="1111" lower_limit="692" upper_limit="1785"/>
                    <measurement group_id="O8" value="283" lower_limit="176" upper_limit="454"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GMRs of Antibodies Against 287-953Antigen (ELISA) After Primary and Booster Vaccination</title>
        <description>Immunogenicity was evaluated by measuring the Geometric mean Ratios (GMRs) after primary and booster vaccination against 287-953Antigen</description>
        <time_frame>month-1, month-2, month-3, month-6 and month-7</time_frame>
        <population>Analysis was performed as per the protocol dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>GMRs of Antibodies Against 287-953Antigen (ELISA) After Primary and Booster Vaccination</title>
          <description>Immunogenicity was evaluated by measuring the Geometric mean Ratios (GMRs) after primary and booster vaccination against 287-953Antigen</description>
          <population>Analysis was performed as per the protocol dataset.</population>
          <units>Ratio</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="35"/>
                <count group_id="O4" value="35"/>
                <count group_id="O5" value="35"/>
                <count group_id="O6" value="35"/>
                <count group_id="O7" value="35"/>
                <count group_id="O8" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GMR Mo 1 to 0 N=34,35,35,32,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.73" lower_limit="3.19" upper_limit="9.05"/>
                    <measurement group_id="O2" value="5.82" lower_limit="3.48" upper_limit="9.73"/>
                    <measurement group_id="O3" value="7.75" lower_limit="4.64" upper_limit="13"/>
                    <measurement group_id="O4" value="5.34" lower_limit="3.12" upper_limit="9.14"/>
                    <measurement group_id="O5" value="5.26" lower_limit="3.14" upper_limit="8.79"/>
                    <measurement group_id="O6" value="6.85" lower_limit="4.09" upper_limit="11"/>
                    <measurement group_id="O7" value="16" lower_limit="9.77" upper_limit="27"/>
                    <measurement group_id="O8" value="1.03" lower_limit="0.62" upper_limit="1.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR Mo 2 to 0 N=34,35,35,31,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" lower_limit="3.2" upper_limit="7.5"/>
                    <measurement group_id="O2" value="4.38" lower_limit="2.88" upper_limit="6.66"/>
                    <measurement group_id="O3" value="70" lower_limit="46" upper_limit="107"/>
                    <measurement group_id="O4" value="112" lower_limit="72" upper_limit="175"/>
                    <measurement group_id="O5" value="3.94" lower_limit="2.59" upper_limit="5.99"/>
                    <measurement group_id="O6" value="4.46" lower_limit="2.93" upper_limit="6.79"/>
                    <measurement group_id="O7" value="116" lower_limit="76" upper_limit="176"/>
                    <measurement group_id="O8" value="0.87" lower_limit="0.57" upper_limit="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR Mo 3 to 0 N=34,35,35,31,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" lower_limit="1.82" upper_limit="4.61"/>
                    <measurement group_id="O2" value="3.54" lower_limit="2.24" upper_limit="5.59"/>
                    <measurement group_id="O3" value="37" lower_limit="24" upper_limit="59"/>
                    <measurement group_id="O4" value="55" lower_limit="34" upper_limit="89"/>
                    <measurement group_id="O5" value="75" lower_limit="47" upper_limit="118"/>
                    <measurement group_id="O6" value="91" lower_limit="58" upper_limit="144"/>
                    <measurement group_id="O7" value="167" lower_limit="105" upper_limit="263"/>
                    <measurement group_id="O8" value="0.88" lower_limit="0.56" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR Mo 6 to 0 N=34,35,35,32,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.56" lower_limit="1.59" upper_limit="4.13"/>
                    <measurement group_id="O2" value="2.06" lower_limit="1.29" upper_limit="3.3"/>
                    <measurement group_id="O3" value="13" lower_limit="8.2" upper_limit="21"/>
                    <measurement group_id="O4" value="13" lower_limit="7.86" upper_limit="21"/>
                    <measurement group_id="O5" value="18" lower_limit="11" upper_limit="29"/>
                    <measurement group_id="O6" value="20" lower_limit="12" upper_limit="31"/>
                    <measurement group_id="O7" value="50" lower_limit="31" upper_limit="80"/>
                    <measurement group_id="O8" value="0.77" lower_limit="0.48" upper_limit="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR Mo 7 to 0 N=34,34,35,31,35,35,35,35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="34" upper_limit="119"/>
                    <measurement group_id="O2" value="1.94" lower_limit="1.03" upper_limit="3.64"/>
                    <measurement group_id="O3" value="89" lower_limit="48" upper_limit="166"/>
                    <measurement group_id="O4" value="11" lower_limit="5.67" upper_limit="21"/>
                    <measurement group_id="O5" value="123" lower_limit="66" upper_limit="229"/>
                    <measurement group_id="O6" value="17" lower_limit="8.9" upper_limit="31"/>
                    <measurement group_id="O7" value="35" lower_limit="19" upper_limit="65"/>
                    <measurement group_id="O8" value="5.9" lower_limit="3.17" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects Reporting Unsolicited AEs Throughout the Study.</title>
        <description>Safety was assessed as the number of subjects who reported unsolicited AEs throughout the study.</description>
        <time_frame>Throughout the study</time_frame>
        <population>Analysis was performed as per the safety dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>rMenB06</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
          </group>
          <group group_id="O2">
            <title>rMenB0</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
          </group>
          <group group_id="O3">
            <title>rMenB016</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
          </group>
          <group group_id="O4">
            <title>rMenB01</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
          </group>
          <group group_id="O5">
            <title>rMenB026</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
          </group>
          <group group_id="O6">
            <title>rMenB02</title>
            <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
          </group>
          <group group_id="O7">
            <title>rMenB012</title>
            <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
          </group>
          <group group_id="O8">
            <title>rMenB6</title>
            <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects Reporting Unsolicited AEs Throughout the Study.</title>
          <description>Safety was assessed as the number of subjects who reported unsolicited AEs throughout the study.</description>
          <population>Analysis was performed as per the safety dataset.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="128"/>
                <count group_id="O2" value="247"/>
                <count group_id="O3" value="128"/>
                <count group_id="O4" value="247"/>
                <count group_id="O5" value="127"/>
                <count group_id="O6" value="253"/>
                <count group_id="O7" value="373"/>
                <count group_id="O8" value="128"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any AE’s</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="137"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="143"/>
                    <measurement group_id="O5" value="72"/>
                    <measurement group_id="O6" value="148"/>
                    <measurement group_id="O7" value="210"/>
                    <measurement group_id="O8" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At least possibly related AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="30"/>
                    <measurement group_id="O4" value="36"/>
                    <measurement group_id="O5" value="24"/>
                    <measurement group_id="O6" value="43"/>
                    <measurement group_id="O7" value="76"/>
                    <measurement group_id="O8" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At least possibly related SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AEs leading to discontinuation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Solicited adverse events (AEs) were collected from Day 1 through 7,Serious AEs were collected throughout the study.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>rMenB06</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 6 months and placebo at 1 and 2 months.</description>
        </group>
        <group group_id="E2">
          <title>rMenB0</title>
          <description>Subjects received 1 dose of rMenB+OMV-NZ at 0 month and 3 doses of placebo at 1, 2 and 6 months.</description>
        </group>
        <group group_id="E3">
          <title>rMenB016</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 6 months and 1 dose of placebo at 2 months.</description>
        </group>
        <group group_id="E4">
          <title>rMenB01</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 1 months and placebo at 2 and 6 months.</description>
        </group>
        <group group_id="E5">
          <title>rMenB026</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 2 and 6 months and 1 dose of placebo at 1 month.</description>
        </group>
        <group group_id="E6">
          <title>rMenB02</title>
          <description>Subjects received 2 doses each of rMenB+OMV-NZ at 0 and 2 months and placebo at 1 and 6 months.</description>
        </group>
        <group group_id="E7">
          <title>rMenB012</title>
          <description>Subjects received 3 doses of rMenB+OMV-NZ at 0, 1 and 2 months and placebo at 6 months.</description>
        </group>
        <group group_id="E8">
          <title>rMenB6</title>
          <description>Subjects received 1 dose of rMenB+OMV-NZ at 6 months and 3 doses of placebo at 0, 1 and 2 months.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>DYSENTERY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>MENINGITIS BACTERlAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>PNEUMONIA VIRAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>SHIGELLAIN FECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>JOINT INJURY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>LIGAMENT RUPTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>ROAD TRAFFIC ACCIDENT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>TOXICITY TO VARlOUS AGENTS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>JUVENILE IDIOPATHIC ARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>ADENOMA BENIGN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>BENGIN OVARIAN TUMOUR</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>CONVULSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>EPILEPSY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>PREMATURE LABOUR</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>MAJOR DEPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>PANIC ATTACK</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>SUICIDE ATTEMPT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>GLOMERULONEPHRITIS MINIMAL LESION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>TESTICULAR TORSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ASTHMATIC CRISIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>URTICARIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>ADENOIDECTOMY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>TONSILLECTOMY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="123" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="238" subjects_at_risk="247"/>
                <counts group_id="E3" subjects_affected="126" subjects_at_risk="128"/>
                <counts group_id="E4" subjects_affected="242" subjects_at_risk="247"/>
                <counts group_id="E5" subjects_affected="118" subjects_at_risk="127"/>
                <counts group_id="E6" subjects_affected="240" subjects_at_risk="253"/>
                <counts group_id="E7" subjects_affected="354" subjects_at_risk="373"/>
                <counts group_id="E8" subjects_affected="125" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="80" subjects_affected="41" subjects_at_risk="128"/>
                <counts group_id="E2" events="120" subjects_affected="80" subjects_at_risk="247"/>
                <counts group_id="E3" events="109" subjects_affected="51" subjects_at_risk="128"/>
                <counts group_id="E4" events="126" subjects_affected="72" subjects_at_risk="247"/>
                <counts group_id="E5" events="72" subjects_affected="42" subjects_at_risk="127"/>
                <counts group_id="E6" events="156" subjects_affected="89" subjects_at_risk="253"/>
                <counts group_id="E7" events="276" subjects_affected="143" subjects_at_risk="373"/>
                <counts group_id="E8" events="90" subjects_affected="49" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>INJECTION SITE ERYTHEMA</sub_title>
                <counts group_id="E1" events="211" subjects_affected="93" subjects_at_risk="128"/>
                <counts group_id="E2" events="338" subjects_affected="162" subjects_at_risk="247"/>
                <counts group_id="E3" events="225" subjects_affected="97" subjects_at_risk="128"/>
                <counts group_id="E4" events="428" subjects_affected="188" subjects_at_risk="247"/>
                <counts group_id="E5" events="251" subjects_affected="94" subjects_at_risk="127"/>
                <counts group_id="E6" events="389" subjects_affected="172" subjects_at_risk="253"/>
                <counts group_id="E7" events="680" subjects_affected="282" subjects_at_risk="373"/>
                <counts group_id="E8" events="169" subjects_affected="86" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>INJECTION SITE INDURATION</sub_title>
                <counts group_id="E1" events="149" subjects_affected="72" subjects_at_risk="128"/>
                <counts group_id="E2" events="240" subjects_affected="130" subjects_at_risk="247"/>
                <counts group_id="E3" events="167" subjects_affected="76" subjects_at_risk="128"/>
                <counts group_id="E4" events="328" subjects_affected="151" subjects_at_risk="247"/>
                <counts group_id="E5" events="191" subjects_affected="82" subjects_at_risk="127"/>
                <counts group_id="E6" events="234" subjects_affected="122" subjects_at_risk="253"/>
                <counts group_id="E7" events="564" subjects_affected="228" subjects_at_risk="373"/>
                <counts group_id="E8" events="116" subjects_affected="58" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>INJECTION SITE PAIN</sub_title>
                <counts group_id="E1" events="378" subjects_affected="122" subjects_at_risk="128"/>
                <counts group_id="E2" events="667" subjects_affected="236" subjects_at_risk="247"/>
                <counts group_id="E3" events="396" subjects_affected="124" subjects_at_risk="128"/>
                <counts group_id="E4" events="729" subjects_affected="237" subjects_at_risk="247"/>
                <counts group_id="E5" events="398" subjects_affected="113" subjects_at_risk="127"/>
                <counts group_id="E6" events="749" subjects_affected="236" subjects_at_risk="253"/>
                <counts group_id="E7" events="1160" subjects_affected="345" subjects_at_risk="373"/>
                <counts group_id="E8" events="398" subjects_affected="123" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>INJECTION SITE SWELLING</sub_title>
                <counts group_id="E1" events="129" subjects_affected="73" subjects_at_risk="128"/>
                <counts group_id="E2" events="244" subjects_affected="132" subjects_at_risk="247"/>
                <counts group_id="E3" events="172" subjects_affected="81" subjects_at_risk="128"/>
                <counts group_id="E4" events="310" subjects_affected="144" subjects_at_risk="247"/>
                <counts group_id="E5" events="171" subjects_affected="76" subjects_at_risk="127"/>
                <counts group_id="E6" events="242" subjects_affected="115" subjects_at_risk="253"/>
                <counts group_id="E7" events="523" subjects_affected="226" subjects_at_risk="373"/>
                <counts group_id="E8" events="92" subjects_affected="55" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>MALAISE</sub_title>
                <counts group_id="E1" events="222" subjects_affected="92" subjects_at_risk="128"/>
                <counts group_id="E2" events="371" subjects_affected="181" subjects_at_risk="247"/>
                <counts group_id="E3" events="238" subjects_affected="96" subjects_at_risk="128"/>
                <counts group_id="E4" events="405" subjects_affected="172" subjects_at_risk="247"/>
                <counts group_id="E5" events="235" subjects_affected="87" subjects_at_risk="127"/>
                <counts group_id="E6" events="444" subjects_affected="185" subjects_at_risk="253"/>
                <counts group_id="E7" events="690" subjects_affected="272" subjects_at_risk="373"/>
                <counts group_id="E8" events="205" subjects_affected="89" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" events="17" subjects_affected="12" subjects_at_risk="128"/>
                <counts group_id="E2" events="11" subjects_affected="8" subjects_at_risk="247"/>
                <counts group_id="E3" events="18" subjects_affected="13" subjects_at_risk="128"/>
                <counts group_id="E4" events="22" subjects_affected="21" subjects_at_risk="247"/>
                <counts group_id="E5" events="20" subjects_affected="18" subjects_at_risk="127"/>
                <counts group_id="E6" events="30" subjects_affected="26" subjects_at_risk="253"/>
                <counts group_id="E7" events="50" subjects_affected="38" subjects_at_risk="373"/>
                <counts group_id="E8" events="27" subjects_affected="20" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="128"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="247"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="128"/>
                <counts group_id="E4" events="10" subjects_affected="10" subjects_at_risk="247"/>
                <counts group_id="E5" events="9" subjects_affected="9" subjects_at_risk="127"/>
                <counts group_id="E6" events="6" subjects_affected="6" subjects_at_risk="253"/>
                <counts group_id="E7" events="14" subjects_affected="14" subjects_at_risk="373"/>
                <counts group_id="E8" events="14" subjects_affected="11" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="128"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="247"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="128"/>
                <counts group_id="E4" events="15" subjects_affected="15" subjects_at_risk="247"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="127"/>
                <counts group_id="E6" events="15" subjects_affected="14" subjects_at_risk="253"/>
                <counts group_id="E7" events="27" subjects_affected="23" subjects_at_risk="373"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="128"/>
                <counts group_id="E2" events="26" subjects_affected="24" subjects_at_risk="247"/>
                <counts group_id="E3" events="18" subjects_affected="18" subjects_at_risk="128"/>
                <counts group_id="E4" events="21" subjects_affected="20" subjects_at_risk="247"/>
                <counts group_id="E5" events="11" subjects_affected="9" subjects_at_risk="127"/>
                <counts group_id="E6" events="30" subjects_affected="28" subjects_at_risk="253"/>
                <counts group_id="E7" events="46" subjects_affected="43" subjects_at_risk="373"/>
                <counts group_id="E8" events="15" subjects_affected="13" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="128"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="247"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="128"/>
                <counts group_id="E4" events="10" subjects_affected="9" subjects_at_risk="247"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="127"/>
                <counts group_id="E6" events="7" subjects_affected="7" subjects_at_risk="253"/>
                <counts group_id="E7" events="24" subjects_affected="21" subjects_at_risk="373"/>
                <counts group_id="E8" events="9" subjects_affected="8" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>TONSILLITIS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="128"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="247"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="128"/>
                <counts group_id="E4" events="9" subjects_affected="7" subjects_at_risk="247"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="127"/>
                <counts group_id="E6" events="7" subjects_affected="6" subjects_at_risk="253"/>
                <counts group_id="E7" events="18" subjects_affected="16" subjects_at_risk="373"/>
                <counts group_id="E8" events="8" subjects_affected="7" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>LIGAMENT SPRAIN</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="128"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="247"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="128"/>
                <counts group_id="E4" events="8" subjects_affected="7" subjects_at_risk="247"/>
                <counts group_id="E5" events="7" subjects_affected="7" subjects_at_risk="127"/>
                <counts group_id="E6" events="7" subjects_affected="7" subjects_at_risk="253"/>
                <counts group_id="E7" events="15" subjects_affected="15" subjects_at_risk="373"/>
                <counts group_id="E8" events="4" subjects_affected="4" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" events="101" subjects_affected="56" subjects_at_risk="128"/>
                <counts group_id="E2" events="131" subjects_affected="76" subjects_at_risk="247"/>
                <counts group_id="E3" events="106" subjects_affected="55" subjects_at_risk="128"/>
                <counts group_id="E4" events="175" subjects_affected="81" subjects_at_risk="247"/>
                <counts group_id="E5" events="81" subjects_affected="39" subjects_at_risk="127"/>
                <counts group_id="E6" events="215" subjects_affected="105" subjects_at_risk="253"/>
                <counts group_id="E7" events="320" subjects_affected="146" subjects_at_risk="373"/>
                <counts group_id="E8" events="77" subjects_affected="44" subjects_at_risk="128"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" events="170" subjects_affected="85" subjects_at_risk="128"/>
                <counts group_id="E2" events="266" subjects_affected="141" subjects_at_risk="247"/>
                <counts group_id="E3" events="187" subjects_affected="91" subjects_at_risk="128"/>
                <counts group_id="E4" events="335" subjects_affected="158" subjects_at_risk="247"/>
                <counts group_id="E5" events="193" subjects_affected="82" subjects_at_risk="127"/>
                <counts group_id="E6" events="357" subjects_affected="160" subjects_at_risk="253"/>
                <counts group_id="E7" events="568" subjects_affected="238" subjects_at_risk="373"/>
                <counts group_id="E8" events="198" subjects_affected="91" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="185" subjects_affected="79" subjects_at_risk="128"/>
                <counts group_id="E2" events="346" subjects_affected="140" subjects_at_risk="247"/>
                <counts group_id="E3" events="256" subjects_affected="88" subjects_at_risk="128"/>
                <counts group_id="E4" events="444" subjects_affected="160" subjects_at_risk="247"/>
                <counts group_id="E5" events="208" subjects_affected="74" subjects_at_risk="127"/>
                <counts group_id="E6" events="452" subjects_affected="165" subjects_at_risk="253"/>
                <counts group_id="E7" events="704" subjects_affected="244" subjects_at_risk="373"/>
                <counts group_id="E8" events="209" subjects_affected="76" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Posting Director</name_or_title>
      <organization>Novartis Vaccines</organization>
      <email>RegistryContactVaccinesUS@novartis.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

